<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38555403</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2396-8370</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>NPJ science of food</Title><ISOAbbreviation>NPJ Sci Food</ISOAbbreviation></Journal><ArticleTitle>Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.</ArticleTitle><Pagination><StartPage>19</StartPage><MedlinePgn>19</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41538-024-00261-2</ELocationID><Abstract><AbstractText>SARS-CoV-2, the etiological agent of COVID-19, is devoid of any metabolic capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic machinery for its replication and propagation. This single-stranded RNA virus with a 29.9&#x2009;kb genome encodes 14 open reading frames (ORFs) and initiates a plethora of virus-host protein-protein interactions in the human body. These extensive viral protein interactions with host-specific cellular targets could trigger severe human metabolic reprogramming/dysregulation (HMRD), a rewiring of sugar-, amino acid-, lipid-, and nucleotide-metabolism(s), as well as altered or impaired bioenergetics, immune dysfunction, and redox imbalance in the body. In the infectious process, the viral pathogen hijacks two major human receptors, angiotensin-converting enzyme (ACE)-2 and/or neuropilin (NRP)-1, for initial adhesion to cell surface; then utilizes two major host proteases, TMPRSS2 and/or furin, to gain cellular entry; and finally employs an endosomal enzyme, cathepsin L (CTSL) for fusogenic release of its viral genome. The virus-induced HMRD results in 5 possible infectious outcomes: asymptomatic, mild, moderate, severe to fatal episodes; while the symptomatic acute COVID-19 condition could manifest into 3 clinical phases: (i) hypoxia and hypoxemia (Warburg effect), (ii) hyperferritinemia ('cytokine storm'), and (iii) thrombocytosis (coagulopathy). The mean incubation period for COVID-19 onset was estimated to be 5.1 days, and most cases develop symptoms after 14 days. The mean viral clearance times were 24, 30, and 39 days for acute, severe, and ICU-admitted COVID-19 patients, respectively. However, about 25-70% of virus-free COVID-19 survivors continue to sustain virus-induced HMRD and exhibit a wide range of symptoms that are persistent, exacerbated, or new 'onset' clinical incidents, collectively termed as post-acute sequelae of COVID-19 (PASC) or long COVID. PASC patients experience several debilitating clinical condition(s) with &gt;200 different and overlapping symptoms that may last for weeks to months. Chronic PASC is a cumulative outcome of at least 10 different HMRD-related pathophysiological mechanisms involving both virus-derived virulence factors and a multitude of innate host responses. Based on HMRD and virus-free clinical impairments of different human organs/systems, PASC patients can be categorized into 4 different clusters or sub-phenotypes: sub-phenotype-1 (33.8%) with cardiac and renal manifestations; sub-phenotype-2 (32.8%) with respiratory, sleep and anxiety disorders; sub-phenotype-3 (23.4%) with skeleto-muscular and nervous disorders; and sub-phenotype-4 (10.1%) with digestive and pulmonary dysfunctions. This narrative review elucidates the effects of viral hijack on host cellular machinery during SARS-CoV-2 infection, ensuing detrimental effect(s) of virus-induced HMRD on human metabolism, consequential symptomatic clinical implications, and damage to multiple organ systems; as well as chronic pathophysiological sequelae in virus-free PASC patients. We have also provided a few evidence-based, human randomized controlled trial (RCT)-tested, precision nutrients to reset HMRD for health recovery of PASC patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naidu</LastName><ForeName>A Satyanarayan</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-6008-0482</Identifier><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA. asnaidu@nterminus.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>N-terminus Research Laboratory, 232659 Via del Rio, Yorba Linda, CA, 92887, USA. asnaidu@nterminus.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chin-Kun</ForeName><Initials>CK</Initials><Identifier Source="ORCID">0000-0001-5371-7847</Identifier><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nutrition, Chung Shan Medical University, 110, Section 1, Jianguo North Road, Taichung, 40201, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Pingfan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Food and Bioengineering, Fujian Polytechnic Normal University, No.1, Campus New Village, Longjiang Street, Fuqing City, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>President-Emeritus, Parker University, 2540 Walnut Hill Lane, Dallas, TX, 75229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clemens</LastName><ForeName>Roger A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0002-5898-9793</Identifier><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Southern California, Alfred E. Mann School of Pharmacy/D. K. Kim International Center for Regulatory &amp; Quality Sciences, 1540 Alcazar St., CHP 140, Los Angeles, CA, 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirakartakusumah</LastName><ForeName>Aman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Union of Food Science and Technology (IUFoST), Guelph, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IPMI International Business School Jakarta; South East Asian Food and Agriculture Science and Technology, IPB University, Bogor, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Hui-Fang</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Taichung Hospital, Ministry of Health &amp; Well-being, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Chi-Hua</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, Chung Shan Medical University Hospital; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porretta</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>President, Italian Association of Food Technology (AITA), Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Station for the Food Preserving Industry, Department of Consumer Science, Viale Tanara 31/a, I-43121, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathai</LastName><ForeName>Issac</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Soukya International Holistic Health Center, Whitefield, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naidu</LastName><ForeName>Sreus A G</ForeName><Initials>SAG</Initials><AffiliationInfo><Affiliation>Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>N-terminus Research Laboratory, 232659 Via del Rio, Yorba Linda, CA, 92887, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Sci Food</MedlineTA><NlmUniqueID>101739627</NlmUniqueID><ISSNLinking>2396-8370</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>NPJ Sci Food. 2024 May 6;8(1):26. doi: 10.1038/s41538-024-00267-w</RefSource><PMID Version="1">38710681</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>31</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>31</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>30</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38555403</ArticleId><ArticleId IdType="pmc">PMC10981760</ArticleId><ArticleId IdType="doi">10.1038/s41538-024-00261-2</ArticleId><ArticleId IdType="pii">10.1038/s41538-024-00261-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu R, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan, S. et al. In the wake of the pandemic: Preparing for long covid [internet]. National Center for Biotechnology Information Available at: https://pubmed.ncbi.nlm.nih.gov/33877759/ (Accessed: 27th March 2024).</Citation></Reference><Reference><Citation>Coronavirus cases: Worldometer Available at: https://www.worldometers.info/coronavirus/ (Accessed: 27th March 2024).</Citation></Reference><Reference><Citation>Hallek M, et al. Post-COVID syndrome. Dtsch. Arztebl. Int. 2023;120:48&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, et al. Long-COVID, metabolic and endocrine disease. Horm. Metab. Res. 2022;54:562&#x2013;566. doi: 10.1055/a-1878-9307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9307</ArticleId><ArticleId IdType="pmc">PMC9363148</ArticleId><ArticleId IdType="pubmed">35724687</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, et al. Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults. Front. Neurol. 2022;13:1012668. doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, et al. New-onset diabetes after COVID-19. J. Clin. Endocrinol. Metab. 2023;108:e1164&#x2013;e1174. doi: 10.1210/clinem/dgad284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad284</ArticleId><ArticleId IdType="pmc">PMC11009784</ArticleId><ArticleId IdType="pubmed">37207448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. Br. J. Haematol. 2020;190:31&#x2013;32. doi: 10.1111/bjh.16786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16786</ArticleId><ArticleId IdType="pmc">PMC7267644</ArticleId><ArticleId IdType="pubmed">32369626</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko, Z. et al. Post-acute sequelae of SARS-COV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection.10.1101/2022.08.08.22278543 (2022).</Citation></Reference><Reference><Citation>Liu X, et al. SARS-CoV-2-host proteome interactions for antiviral drug discovery. Mol. Syst. Biol. 2021;17:e10396. doi: 10.15252/msb.202110396.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110396</ArticleId><ArticleId IdType="pmc">PMC8552907</ArticleId><ArticleId IdType="pubmed">34709727</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. In vivo structure and dynamics of the SARS-CoV-2 RNA genome. Nat. Commun. 2021;12:5695. doi: 10.1038/s41467-021-25999-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25999-1</ArticleId><ArticleId IdType="pmc">PMC8478942</ArticleId><ArticleId IdType="pubmed">34584097</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburton PE, Sebra RP. Long-read DNA sequencing: recent advances and remaining challenges. Annu. Rev. Genom. Hum. Genet. 2023;24:109&#x2013;132. doi: 10.1146/annurev-genom-101722-103045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-101722-103045</ArticleId><ArticleId IdType="pubmed">37075062</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee AK, et al. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell. 2020;183:1325&#x2013;1339.e21. doi: 10.1016/j.cell.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med. 2021;2:99&#x2013;112.e7. doi: 10.1016/j.medj.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, et al. Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions. Nat. Commun. 2021;12:5113. doi: 10.1038/s41467-021-25357-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25357-1</ArticleId><ArticleId IdType="pmc">PMC8387478</ArticleId><ArticleId IdType="pubmed">34433821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, et al. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. EMBO J. 2021;40:e107776. doi: 10.15252/embj.2021107776.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107776</ArticleId><ArticleId IdType="pmc">PMC8447597</ArticleId><ArticleId IdType="pubmed">34232536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, et al. COVID-19 metabolism: mechanisms and therapeutic targets. MedComm. 2022;3:e157. doi: 10.1002/mco2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.157</ArticleId><ArticleId IdType="pmc">PMC9363584</ArticleId><ArticleId IdType="pubmed">35958432</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu, A. S. et al. SARS-COV-2-induced host metabolic reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and post-acute sequelae of covid-19 (PASC). J. Food Bioactives18, (2022).</Citation></Reference><Reference><Citation>Gordon DE, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gussow AB, et al. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses. Proc. Natl Acad. Sci. USA. 2020;117:15193&#x2013;15199. doi: 10.1073/pnas.2008176117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008176117</ArticleId><ArticleId IdType="pmc">PMC7334499</ArticleId><ArticleId IdType="pubmed">32522874</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600:408&#x2013;418. doi: 10.1038/s41586-021-04188-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04188-6</ArticleId><ArticleId IdType="pubmed">34880490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sicari D, Chatziioannou A, Koutsandreas T, Sitia R, Chevet E. Role of the early secretory pathway in SARS-CoV-2 infection. J. Cell Biol. 2020;219:e202006005. doi: 10.1083/jcb.202006005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202006005</ArticleId><ArticleId IdType="pmc">PMC7480111</ArticleId><ArticleId IdType="pubmed">32725137</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu SAG, Clemens RA, Naidu AS. SARS-CoV-2 infection dysregulates host iron (Fe)-redox homeostasis (Fe-R-H): role of Fe-redox regulators, ferroptosis inhibitors, anticoagulants, and iron-chelators in COVID-19 control. J. Diet. Suppl. 2023;20:312&#x2013;371. doi: 10.1080/19390211.2022.2075072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2022.2075072</ArticleId><ArticleId IdType="pubmed">35603834</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C, Zhong Q, Gao GF. Overview of SARS-CoV-2 genome-encoded proteins. Sci. China Life Sci. 2022;65:280&#x2013;294. doi: 10.1007/s11427-021-1964-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-021-1964-4</ArticleId><ArticleId IdType="pmc">PMC8362648</ArticleId><ArticleId IdType="pubmed">34387838</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12:372. doi: 10.3390/v12040372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040372</ArticleId><ArticleId IdType="pmc">PMC7232198</ArticleId><ArticleId IdType="pubmed">32230900</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donoghue SI, et al. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms. Mol. Syst. Biol. 2021;17:e10079. doi: 10.15252/msb.202010079.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202010079</ArticleId><ArticleId IdType="pmc">PMC8438690</ArticleId><ArticleId IdType="pubmed">34519429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, et al. The SARS-CoV-2 RNA interactome. Mol. Cell. 2021;81:2838&#x2013;2850.e6. doi: 10.1016/j.molcel.2021.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.04.022</ArticleId><ArticleId IdType="pmc">PMC8075806</ArticleId><ArticleId IdType="pubmed">33989516</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeoni M, Cavinato T, Rodriguez D, Gatfield D. I(nsp1)ecting SARS-CoV-2-ribosome interactions. Commun. Biol. 2021;4:715. doi: 10.1038/s42003-021-02265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02265-0</ArticleId><ArticleId IdType="pmc">PMC8192748</ArticleId><ArticleId IdType="pubmed">34112887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat. Biotechnol. 2023;41:128&#x2013;139. doi: 10.1038/s41587-022-01474-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01474-0</ArticleId><ArticleId IdType="pmc">PMC9851973</ArticleId><ArticleId IdType="pubmed">36217030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee J, et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2022;610:381&#x2013;388. doi: 10.1038/s41586-022-05282-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05282-z</ArticleId><ArticleId IdType="pmc">PMC9533993</ArticleId><ArticleId IdType="pubmed">36198800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, et al. Allosteric activation of SARS-CoV-2 RNA-dependent RNA polymerase by remdesivir triphosphate and other phosphorylated nucleotides. mBio. 2021;12:e0142321. doi: 10.1128/mBio.01423-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01423-21</ArticleId><ArticleId IdType="pmc">PMC8262916</ArticleId><ArticleId IdType="pubmed">34154407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat. Commun. 2021;12:1676. doi: 10.1038/s41467-021-21903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21903-z</ArticleId><ArticleId IdType="pmc">PMC7960988</ArticleId><ArticleId IdType="pubmed">33723254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoli M, et al. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation. J. Virol. 2010;84:647&#x2013;660. doi: 10.1128/JVI.00769-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00769-09</ArticleId><ArticleId IdType="pmc">PMC2798449</ArticleId><ArticleId IdType="pubmed">19846525</ArticleId></ArticleIdList></Reference><Reference><Citation>Bera SC, et al. The nucleotide addition cycle of the SARS-CoV-2 polymerase. Cell Rep. 2021;36:109650. doi: 10.1016/j.celrep.2021.109650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109650</ArticleId><ArticleId IdType="pmc">PMC8367775</ArticleId><ArticleId IdType="pubmed">34433083</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias SSG, et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020;16:e1009127. doi: 10.1371/journal.ppat.1009127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009127</ArticleId><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Casari I, Manfredi M, Metharom P, Falasca M. Dissecting lipid metabolism alterations in SARS-CoV-2. Prog. Lipid Res. 2021;82:101092. doi: 10.1016/j.plipres.2021.101092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2021.101092</ArticleId><ArticleId IdType="pmc">PMC7869689</ArticleId><ArticleId IdType="pubmed">33571544</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Beneit F, Ra&#x161;kevi&#x10d;ius V, Skeberdis VA, Bordel S. A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19. Sci. Rep. 2021;11:11982. doi: 10.1038/s41598-021-91526-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91526-3</ArticleId><ArticleId IdType="pmc">PMC8184994</ArticleId><ArticleId IdType="pubmed">34099831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardacci R, et al. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis. 2021;12:263. doi: 10.1038/s41419-021-03527-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03527-9</ArticleId><ArticleId IdType="pmc">PMC7952828</ArticleId><ArticleId IdType="pubmed">33712574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi KH, McCullagh JSO. A lipidomic view of SARS-CoV-2. Biosci. Rep. 2021;41:BSR20210953. doi: 10.1042/BSR20210953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210953</ArticleId><ArticleId IdType="pmc">PMC8350433</ArticleId><ArticleId IdType="pubmed">34313294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper PL. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies. Cell Stress Chaperones. 2020;25:707&#x2013;710. doi: 10.1007/s12192-020-01126-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-020-01126-9</ArticleId><ArticleId IdType="pmc">PMC7271958</ArticleId><ArticleId IdType="pubmed">32500379</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Wasan H, Reeta KH. Heme oxygenase-1 modulation: a potential therapeutic target for COVID-19 and associated complications. Free Radic. Biol. Med. 2020;161:263&#x2013;271. doi: 10.1016/j.freeradbiomed.2020.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7571447</ArticleId><ArticleId IdType="pubmed">33091573</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza JA, Gonz&#xe1;lez PA, Kalergis AM. Modulation of antiviral immunity by heme oxygenase-1. Am. J. Pathol. 2017;187:487&#x2013;493. doi: 10.1016/j.ajpath.2016.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2016.11.011</ArticleId><ArticleId IdType="pubmed">28082120</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaundal RK, Kalvala AK, Kumar A. Neurological implications of COVID-19: role of redox imbalance and mitochondrial dysfunction. Mol. Neurobiol. 2021;58:4575&#x2013;4587. doi: 10.1007/s12035-021-02412-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02412-y</ArticleId><ArticleId IdType="pmc">PMC8190166</ArticleId><ArticleId IdType="pubmed">34110602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-P, et al. Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress. EMBO J. 2014;33:1304&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194121</ArticleId><ArticleId IdType="pubmed">24769394</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, et al. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J. Proteome Res. 2020;19:4455&#x2013;4469. doi: 10.1021/acs.jproteome.0c00606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00606</ArticleId><ArticleId IdType="pmc">PMC7640979</ArticleId><ArticleId IdType="pubmed">33103907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong HT, Cheung V, Salamango DJ. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism. J. Cell Sci. 2022;135:jcs259666. doi: 10.1242/jcs.259666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.259666</ArticleId><ArticleId IdType="pubmed">35187564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang J, Wang L, Aliyari S, Cheng G. SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1. Cell Mol. Immunol. 2022;19:872&#x2013;882. doi: 10.1038/s41423-022-00887-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00887-w</ArticleId><ArticleId IdType="pmc">PMC9217730</ArticleId><ArticleId IdType="pubmed">35732914</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl Acad. Sci. USA. 2020;117:11727&#x2013;11734. doi: 10.1073/pnas.2003138117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, P&#xf6;hlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell. 2020;78:779&#x2013;784.e5. doi: 10.1016/j.molcel.2020.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JP, Liu S-L. Role of host factors in SARS-CoV-2 entry. J. Biol. Chem. 2021;297:100847. doi: 10.1016/j.jbc.2021.100847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100847</ArticleId><ArticleId IdType="pmc">PMC8160279</ArticleId><ArticleId IdType="pubmed">34058196</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343&#x2013;355. doi: 10.1038/s41422-020-0305-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0305-x</ArticleId><ArticleId IdType="pmc">PMC7104723</ArticleId><ArticleId IdType="pubmed">32231345</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng R, Wu L-A, Wang Q, Qi J, Gao GF. Cell entry by SARS-CoV-2. Trends Biochem Sci. 2021;46:848&#x2013;860. doi: 10.1016/j.tibs.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8180548</ArticleId><ArticleId IdType="pubmed">34187722</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo R, Bugge TH. Membrane-anchored serine proteases in vertebrate cell and developmental biology. Annu. Rev. Cell Dev. Biol. 2011;27:213&#x2013;235. doi: 10.1146/annurev-cellbio-092910-154247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-092910-154247</ArticleId><ArticleId IdType="pmc">PMC3391589</ArticleId><ArticleId IdType="pubmed">21721945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016&#x2013;1035.e19. doi: 10.1016/j.cell.2020.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadanec LK, et al. Can SARS-CoV-2 virus use multiple receptors to enter host cells? Int J. Mol. Sci. 2021;22:992. doi: 10.3390/ijms22030992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22030992</ArticleId><ArticleId IdType="pmc">PMC7863934</ArticleId><ArticleId IdType="pubmed">33498183</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861&#x2013;865. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z-L, Buck M. Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2. Biophys. J. 2021;120:2828&#x2013;2837. doi: 10.1016/j.bpj.2021.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.026</ArticleId><ArticleId IdType="pmc">PMC8169233</ArticleId><ArticleId IdType="pubmed">34087218</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock TP, et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat. Microbiol. 2021;6:899&#x2013;909. doi: 10.1038/s41564-021-00908-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00908-w</ArticleId><ArticleId IdType="pubmed">33907312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation. Proc. Natl Acad. Sci. USA. 2021;118:e2109905118. doi: 10.1073/pnas.2109905118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109905118</ArticleId><ArticleId IdType="pmc">PMC8617502</ArticleId><ArticleId IdType="pubmed">34732583</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker GR, Daniel S, Millet JK. Coronavirus entry: how we arrived at SARS-CoV-2. Curr. Opin. Virol. 2021;47:113&#x2013;120. doi: 10.1016/j.coviro.2021.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.02.006</ArticleId><ArticleId IdType="pmc">PMC7942143</ArticleId><ArticleId IdType="pubmed">33744490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragia G, Manolopoulos VG. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies. Eur. J. Clin. Pharm. 2020;76:1623&#x2013;1630. doi: 10.1007/s00228-020-02963-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-02963-4</ArticleId><ArticleId IdType="pmc">PMC7372205</ArticleId><ArticleId IdType="pubmed">32696234</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton DJ, et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020;588:327&#x2013;330. doi: 10.1038/s41586-020-2772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2772-0</ArticleId><ArticleId IdType="pmc">PMC7116727</ArticleId><ArticleId IdType="pubmed">32942285</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbar Saadat Y, Hosseiniyan Khatibi SM, Zununi Vahed S, Ardalan M. Host serine proteases: a potential targeted therapy for COVID-19 and influenza. Front Mol. Biosci. 2021;8:725528. doi: 10.3389/fmolb.2021.725528.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.725528</ArticleId><ArticleId IdType="pmc">PMC8435734</ArticleId><ArticleId IdType="pubmed">34527703</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281&#x2013;292.e6. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450&#x2013;452. doi: 10.1038/s41591-020-0820-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId><ArticleId IdType="pmc">PMC7095063</ArticleId><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>Essalmani R, et al. Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. J. Virol. 2022;96:e0012822. doi: 10.1128/jvi.00128-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00128-22</ArticleId><ArticleId IdType="pmc">PMC9044946</ArticleId><ArticleId IdType="pubmed">35343766</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vankadari N. Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence. J. Phys. Chem. Lett. 2020;11:6655&#x2013;6663. doi: 10.1021/acs.jpclett.0c01698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpclett.0c01698</ArticleId><ArticleId IdType="pubmed">32787225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Limburg H, et al. TMPRSS2 is the major activating protease of influenza a virus in primary human airway cells and influenza B virus in human type II pneumocytes. J. Virol. 2019;93:e00649&#x2013;19. doi: 10.1128/JVI.00649-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00649-19</ArticleId><ArticleId IdType="pmc">PMC6803253</ArticleId><ArticleId IdType="pubmed">31391268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M-M, et al. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct. Target Ther. 2021;6:134. doi: 10.1038/s41392-021-00558-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00558-8</ArticleId><ArticleId IdType="pmc">PMC7997800</ArticleId><ArticleId IdType="pubmed">33774649</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doremalen N, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020;382:1564&#x2013;1567. doi: 10.1056/NEJMc2004973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2004973</ArticleId><ArticleId IdType="pmc">PMC7121658</ArticleId><ArticleId IdType="pubmed">32182409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R, et al. The total number and mass of SARS-CoV-2 virions. Proc. Natl Acad. Sci. USA. 2021;118:e2024815118. doi: 10.1073/pnas.2024815118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024815118</ArticleId><ArticleId IdType="pmc">PMC8237675</ArticleId><ArticleId IdType="pubmed">34083352</ArticleId></ArticleIdList></Reference><Reference><Citation>Folgueira MD, Luczkowiak J, Lasala F, P&#xe9;rez-Rivilla A, Delgado R. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19. Clin. Microbiol. Infect. 2021;27:886&#x2013;891. doi: 10.1016/j.cmi.2021.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.014</ArticleId><ArticleId IdType="pmc">PMC7898982</ArticleId><ArticleId IdType="pubmed">33631334</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. The kinetics of viral load and antibodies to SARS-CoV-2. Clin. Microbiol. Infect. 2020;26:1690.e1&#x2013;1690.e4. doi: 10.1016/j.cmi.2020.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.08.043</ArticleId><ArticleId IdType="pmc">PMC7474805</ArticleId><ArticleId IdType="pubmed">32898715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong DWL, et al. Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells. 2021;10:1900. doi: 10.3390/cells10081900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081900</ArticleId><ArticleId IdType="pmc">PMC8394956</ArticleId><ArticleId IdType="pubmed">34440669</ArticleId></ArticleIdList></Reference><Reference><Citation>Caceres PS, et al. High SARS-CoV-2 viral load in urine sediment correlates with acute kidney injury and poor COVID-19 outcome. J. Am. Soc. Nephrol. 2021;32:2517&#x2013;2528. doi: 10.1681/ASN.2021010059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021010059</ArticleId><ArticleId IdType="pmc">PMC8722807</ArticleId><ArticleId IdType="pubmed">34088853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Obach M, et al. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J. Biol. Chem. 2004;279:53562&#x2013;53570. doi: 10.1074/jbc.M406096200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406096200</ArticleId><ArticleId IdType="pubmed">15466858</ArticleId></ArticleIdList></Reference><Reference><Citation>Palsson-McDermott EM, O&#x2019;Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35:965&#x2013;973. doi: 10.1002/bies.201300084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201300084</ArticleId><ArticleId IdType="pubmed">24115022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro E, German&#xf2; M, Mollace R, Mollace V, Malara N. HIF-1, the Warburg effect, and macrophage/microglia polarization potential role in COVID-19 pathogenesis. Oxid. Med. Cell Longev. 2021;2021:8841911. doi: 10.1155/2021/8841911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8841911</ArticleId><ArticleId IdType="pmc">PMC7987467</ArticleId><ArticleId IdType="pubmed">33815663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DG, O&#x2019;Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu. Rev. Immunol. 2020;38:289&#x2013;313. doi: 10.1146/annurev-immunol-081619-104850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-081619-104850</ArticleId><ArticleId IdType="pubmed">31986069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrzadi S, Karimi MY, Fatemi A, Reiter RJ, Hosseinzadeh A. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharm. Ther. 2021;224:107825. doi: 10.1016/j.pharmthera.2021.107825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107825</ArticleId><ArticleId IdType="pmc">PMC7919585</ArticleId><ArticleId IdType="pubmed">33662449</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J. Inflamm. (Lond.) 2020;17:33. doi: 10.1186/s12950-020-00263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-020-00263-3</ArticleId><ArticleId IdType="pmc">PMC7594974</ArticleId><ArticleId IdType="pubmed">33139969</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti M. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann. Hematol. 2020;99:1701&#x2013;1707. doi: 10.1007/s00277-020-04138-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04138-8</ArticleId><ArticleId IdType="pmc">PMC7312112</ArticleId><ArticleId IdType="pubmed">32583086</ArticleId></ArticleIdList></Reference><Reference><Citation>Debuc B, Smadja DM. Is COVID-19 a new hematologic disease? Stem Cell Rev. Rep. 2021;17:4&#x2013;8. doi: 10.1007/s12015-020-09987-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-09987-4</ArticleId><ArticleId IdType="pmc">PMC7217340</ArticleId><ArticleId IdType="pubmed">32399806</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeas M, Saleh J, Peyssonnaux C. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis? Int. J. Infect. Dis. 2020;97:303&#x2013;305. doi: 10.1016/j.ijid.2020.05.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId><ArticleId IdType="pmc">PMC7264936</ArticleId><ArticleId IdType="pubmed">32497811</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Lan C, et al. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood. 2005;105:4527&#x2013;4531. doi: 10.1182/blood-2004-09-3468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-09-3468</ArticleId><ArticleId IdType="pubmed">15671444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 Infection. J. Clin. Med. 2020;9:2429. doi: 10.3390/jcm9082429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082429</ArticleId><ArticleId IdType="pmc">PMC7464087</ArticleId><ArticleId IdType="pubmed">32751400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhoberac BB. What can cellular redox, iron, and reactive oxygen species suggest about the mechanisms and potential therapy of COVID-19? Front. Cell Infect. Microbiol. 2020;10:569709. doi: 10.3389/fcimb.2020.569709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.569709</ArticleId><ArticleId IdType="pmc">PMC7767833</ArticleId><ArticleId IdType="pubmed">33381464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18:1094&#x2013;1099. doi: 10.1111/jth.14817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankun J, Landeta P, Pretorius E, Skrzypczak-Jankun E, Lipinski B. Unusual clotting dynamics of plasma supplemented with iron(III) Int J. Mol. Med. 2014;33:367&#x2013;372. doi: 10.3892/ijmm.2013.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2013.1585</ArticleId><ArticleId IdType="pubmed">24337469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D-W, et al. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel? Clin. Chim. Acta. 2020;508:122&#x2013;129. doi: 10.1016/j.cca.2020.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.05.027</ArticleId><ArticleId IdType="pmc">PMC7224669</ArticleId><ArticleId IdType="pubmed">32417210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi G, et al. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin. Exp. Med. 2021;21:239&#x2013;246. doi: 10.1007/s10238-020-00679-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00679-4</ArticleId><ArticleId IdType="pmc">PMC7790728</ArticleId><ArticleId IdType="pubmed">33417082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagener FADTG, Pickkers P, Peterson SJ, Immenschuh S, Abraham NG. Targeting the heme-heme oxygenase system to prevent severe complications following COVID-19 infections. Antioxid. (Basel) 2020;9:540. doi: 10.3390/antiox9060540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9060540</ArticleId><ArticleId IdType="pmc">PMC7346191</ArticleId><ArticleId IdType="pubmed">32575554</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, et al. The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients. Infect. Dis. Poverty. 2021;10:119. doi: 10.1186/s40249-021-00901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00901-9</ArticleId><ArticleId IdType="pmc">PMC8446477</ArticleId><ArticleId IdType="pubmed">34535192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer SA, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 2020;172:577&#x2013;582. doi: 10.7326/M20-0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0504</ArticleId><ArticleId IdType="pmc">PMC7081172</ArticleId><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, et al. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw. Open. 2022;5:e2228008. doi: 10.1001/jamanetworkopen.2022.28008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.28008</ArticleId><ArticleId IdType="pmc">PMC9396366</ArticleId><ArticleId IdType="pubmed">35994285</ArticleId></ArticleIdList></Reference><Reference><Citation>Samrah SM, et al. Viral clearance course of COVID-19 outbreaks. J. Multidiscip. Health. 2021;14:555&#x2013;565. doi: 10.2147/JMDH.S302891.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S302891</ArticleId><ArticleId IdType="pmc">PMC7941054</ArticleId><ArticleId IdType="pubmed">33707949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirai N, et al. Factors associated with viral clearance periods from patients with COVID-19: a retrospective observational cohort study. J. Infect. Chemother. 2021;27:864&#x2013;868. doi: 10.1016/j.jiac.2021.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2021.02.015</ArticleId><ArticleId IdType="pmc">PMC7891070</ArticleId><ArticleId IdType="pubmed">33642249</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Lai CL. SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement? Cell Death Discov. 2020;6:130. doi: 10.1038/s41420-020-00369-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00369-w</ArticleId><ArticleId IdType="pmc">PMC7687212</ArticleId><ArticleId IdType="pubmed">33251029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KS, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a hong kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A. Effects of pancreatic SARS-CoV-2 infection identified. Nat. Rev. Endocrinol. 2021;17:192. doi: 10.1038/s41574-021-00481-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00481-6</ArticleId><ArticleId IdType="pmc">PMC7903214</ArticleId><ArticleId IdType="pubmed">33627835</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID-19: prevalence, clinical significance and therapeutic implications. Rev. Endocr. Metab. Disord. 2022;23:299&#x2013;308. doi: 10.1007/s11154-021-09655-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09655-z</ArticleId><ArticleId IdType="pmc">PMC8041474</ArticleId><ArticleId IdType="pubmed">33846867</ArticleId></ArticleIdList></Reference><Reference><Citation>Deodatus JA, et al. Lower plasma calcium associated with COVID-19, but not with disease severity: a two-centre retrospective cohort study. Infect. Dis. (Lond.) 2022;54:90&#x2013;98. doi: 10.1080/23744235.2021.1981549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1981549</ArticleId><ArticleId IdType="pmc">PMC8500306</ArticleId><ArticleId IdType="pubmed">34586002</ArticleId></ArticleIdList></Reference><Reference><Citation>Alayash AI. The impact of COVID-19 infection on oxygen homeostasis: a molecular perspective. Front. Physiol. 2021;12:711976. doi: 10.3389/fphys.2021.711976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.711976</ArticleId><ArticleId IdType="pmc">PMC8532809</ArticleId><ArticleId IdType="pubmed">34690793</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, et al. Ectopic expression of SARS-CoV-2 S and ORF-9B proteins alters metabolic profiles and impairs contractile function in cardiomyocytes. Front. Cell Dev. Biol. 2023;11:1110271. doi: 10.3389/fcell.2023.1110271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2023.1110271</ArticleId><ArticleId IdType="pmc">PMC9994814</ArticleId><ArticleId IdType="pubmed">36910162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long COVID: does SARS-CoV-2 induce lingering brain lesions? Eur. J. Neurol. 2023;30:1165&#x2013;1166. doi: 10.1111/ene.15751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15751</ArticleId><ArticleId IdType="pubmed">36802122</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr. Probl. Cardiol. 2020;45:100618. doi: 10.1016/j.cpcardiol.2020.100618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, et al. Long-term consequences of COVID-19: research needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 2023;29:226&#x2013;235. doi: 10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu. Rev. Med. 2023;74:55&#x2013;64. doi: 10.1146/annurev-med-043021-030635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. (Lond.) 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez M, et al. Spinal manipulation for the management of cervicogenic headache: a systematic review and meta-analysis. Eur. J. Pain. 2020;24:1687&#x2013;1702. doi: 10.1002/ejp.1632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1632</ArticleId><ArticleId IdType="pubmed">32621321</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76:405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C-C, et al. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J. Biol. Sci. 2022;18:4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moolamalla STR, Balasubramanian R, Chauhan R, Priyakumar UD, Vinod PK. Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach. Micro. Pathog. 2021;158:105114. doi: 10.1016/j.micpath.2021.105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105114</ArticleId><ArticleId IdType="pmc">PMC8321700</ArticleId><ArticleId IdType="pubmed">34333072</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T, Wang T. Metabolic reprogramming in COVID-19. Int J. Mol. Sci. 2021;22:11475. doi: 10.3390/ijms222111475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111475</ArticleId><ArticleId IdType="pmc">PMC8584248</ArticleId><ArticleId IdType="pubmed">34768906</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;brain fog&#x2019; and results in behavioral changes that favor viral survival. Med Sci. Monit. 2021;27:e930886. doi: 10.12659/MSM.930886.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S, Das N, Mukherjee P. Picking up a fight: fine tuning mitochondrial innate immune defenses against RNA viruses. Front Microbiol. 2020;11:1990. doi: 10.3389/fmicb.2020.01990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01990</ArticleId><ArticleId IdType="pmc">PMC7487669</ArticleId><ArticleId IdType="pubmed">32983015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AVW, Guy GW, Brysch W, Bell JD. Understanding long COVID; mitochondrial health and adaptation-old pathways, new problems. Biomedicines. 2022;10:3113. doi: 10.3390/biomedicines10123113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123113</ArticleId><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients&#x2019; performance: a prospective observational cohort study. Respir. Res. 2020;21:276. doi: 10.1186/s12931-020-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessling-Resnick M. Crossing the iron gate: why and how transferrin receptors mediate viral entry. Annu. Rev. Nutr. 2018;38:431&#x2013;458. doi: 10.1146/annurev-nutr-082117-051749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-082117-051749</ArticleId><ArticleId IdType="pmc">PMC6743070</ArticleId><ArticleId IdType="pubmed">29852086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. a narrative review. Clin. Pr. 2020;10:1271. doi: 10.4081/cp.2020.1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzhong L, Hualan L. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system. Autoimmunity. 2021;54:213&#x2013;224. doi: 10.1080/08916934.2021.1913581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2021.1913581</ArticleId><ArticleId IdType="pmc">PMC8074649</ArticleId><ArticleId IdType="pubmed">33899609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechuga GC, et al. SARS-CoV-2 proteins bind to hemoglobin and its metabolites. Int J. Mol. Sci. 2021;22:9035. doi: 10.3390/ijms22169035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22169035</ArticleId><ArticleId IdType="pmc">PMC8396565</ArticleId><ArticleId IdType="pubmed">34445741</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829&#x2013;2845. doi: 10.1111/all.14429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri PE, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur. J. Epidemiol. 2020;35:763&#x2013;773. doi: 10.1007/s10654-020-00678-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00678-5</ArticleId><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y, et al. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol. Ther. 2020;33:e13871. doi: 10.1111/dth.13871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13871</ArticleId><ArticleId IdType="pmc">PMC7323108</ArticleId><ArticleId IdType="pubmed">32558055</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pastora J, et al. Hyperferritinemia in critically ill COVID-19 patients&#x2014;Is ferritin the product of inflammation or a pathogenic mediator? Clin. Chim. Acta. 2020;509:249&#x2013;251. doi: 10.1016/j.cca.2020.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.06.033</ArticleId><ArticleId IdType="pmc">PMC7306200</ArticleId><ArticleId IdType="pubmed">32579952</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J. Infect. Dis. 2020;95:332&#x2013;339. doi: 10.1016/j.ijid.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7195003</ArticleId><ArticleId IdType="pubmed">32334118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Jiang J, Fu N, Chen L. Targetting ferroptosis for blood cell-related diseases. J. Drug Target. 2022;30:244&#x2013;258. doi: 10.1080/1061186X.2021.1971237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2021.1971237</ArticleId><ArticleId IdType="pubmed">34415804</ArticleId></ArticleIdList></Reference><Reference><Citation>Handy DE, Loscalzo J. Redox regulation of mitochondrial function. Antioxid. Redox Signal. 2012;16:1323&#x2013;1367. doi: 10.1089/ars.2011.4123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4123</ArticleId><ArticleId IdType="pmc">PMC3324814</ArticleId><ArticleId IdType="pubmed">22146081</ArticleId></ArticleIdList></Reference><Reference><Citation>Koklesova L, et al. Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine. EPMA J. 2021;12:27&#x2013;40. doi: 10.1007/s13167-021-00237-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00237-2</ArticleId><ArticleId IdType="pmc">PMC7931170</ArticleId><ArticleId IdType="pubmed">33686350</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C, et al. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front Microbiol. 2021;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe3;o PR, et al. Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection. Int. Immunopharmacol. 2022;108:108697. doi: 10.1016/j.intimp.2022.108697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.108697</ArticleId><ArticleId IdType="pmc">PMC8920784</ArticleId><ArticleId IdType="pubmed">35405594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma NK, Sarode SC. Do compromised mitochondria aggravate severity and fatality by SARS-CoV-2? Curr. Med. Res. Opin. 2022;38:911&#x2013;916. doi: 10.1080/03007995.2022.2065140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2065140</ArticleId><ArticleId IdType="pmc">PMC9115783</ArticleId><ArticleId IdType="pubmed">35403526</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria-Castro E, et al. The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection. Histol. Histopathol. 2021;36:947&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pubmed">34132382</ArticleId></ArticleIdList></Reference><Reference><Citation>Turton N, Millichap L, Hargreaves IP. Potential biomarkers of mitochondrial dysfunction associated with COVID-19 infection. Adv. Exp. Med. Biol. 2023;1412:211&#x2013;224. doi: 10.1007/978-3-031-28012-2_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-031-28012-2_11</ArticleId><ArticleId IdType="pubmed">37378769</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 2020;319:C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela R, et al. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biol. 2021;46:102078. doi: 10.1016/j.redox.2021.102078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102078</ArticleId><ArticleId IdType="pmc">PMC8346680</ArticleId><ArticleId IdType="pubmed">34333284</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s-Aguayo JJ, et al. Mitochondria and mitochondrial DNA: key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Med. (Kaunas.) 2021;57:928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8471487</ArticleId><ArticleId IdType="pubmed">34577851</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa TJ, et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vasc. Pharm. 2022;142:106946. doi: 10.1016/j.vph.2021.106946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106946</ArticleId><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>de Las Heras N, Mart&#xed;n Gim&#xe9;nez VM, Ferder L, Manucha W, Lahera V. Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D. Antioxid. (Basel) 2020;9:897. doi: 10.3390/antiox9090897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090897</ArticleId><ArticleId IdType="pmc">PMC7555731</ArticleId><ArticleId IdType="pubmed">32967329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y, et al. Mitochondrial dysfunction associates with acute T lymphocytopenia and impaired functionality in COVID-19 patients. Front Immunol. 2021;12:799896. doi: 10.3389/fimmu.2021.799896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.799896</ArticleId><ArticleId IdType="pmc">PMC8795605</ArticleId><ArticleId IdType="pubmed">35095881</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, et al. Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J. Neuroimmune Pharm. 2021;16:770&#x2013;784. doi: 10.1007/s11481-021-10015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliss A, Kuzmin AN, Prasad PN, Mahajan SD. Mitochondrial dysfunction: a prelude to neuropathogenesis of SARS-CoV-2. ACS Chem. Neurosci. 2022;13:308&#x2013;312. doi: 10.1021/acschemneuro.1c00675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00675</ArticleId><ArticleId IdType="pmc">PMC8790819</ArticleId><ArticleId IdType="pubmed">35049274</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu SAG, Wallace TC, Davies KJA, Naidu AS. Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19. J. Diet. Suppl. 2023;20:218&#x2013;253. doi: 10.1080/19390211.2021.1922567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2021.1922567</ArticleId><ArticleId IdType="pubmed">33977807</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, et al. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol. Med. 2020;12:e13001. doi: 10.15252/emmm.202013001.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013001</ArticleId><ArticleId IdType="pmc">PMC7645870</ArticleId><ArticleId IdType="pubmed">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T-H, Chang C-J, Hung P-H. Possible pathogenesis and prevention of long COVID: SARS-CoV-2-induced mitochondrial disorder. Int J. Mol. Sci. 2023;24:8034. doi: 10.3390/ijms24098034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098034</ArticleId><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="pubmed">37175745</ArticleId></ArticleIdList></Reference><Reference><Citation>McCully KS. Review: chemical pathology of homocysteine VI. Aging, cellular senescence, and mitochondrial dysfunction. Ann. Clin. Lab Sci. 2018;48:677&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">30373877</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm. Res. 2020;69:1077&#x2013;1085. doi: 10.1007/s00011-020-01389-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01389-z</ArticleId><ArticleId IdType="pmc">PMC7410962</ArticleId><ArticleId IdType="pubmed">32767095</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno Fern&#xe1;ndez-Ayala DJ, Navas P, L&#xf3;pez-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp. Gerontol. 2020;142:111147. doi: 10.1016/j.exger.2020.111147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId><ArticleId IdType="pmc">PMC7648491</ArticleId><ArticleId IdType="pubmed">33171276</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfarouk KO, et al. Of mitochondrion and COVID-19. J. Enzym. Inhib. Med. Chem. 2021;36:1258&#x2013;1267. doi: 10.1080/14756366.2021.1937144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2021.1937144</ArticleId><ArticleId IdType="pmc">PMC8205080</ArticleId><ArticleId IdType="pubmed">34107824</ArticleId></ArticleIdList></Reference><Reference><Citation>Betteridge DJ. What is oxidative stress? Metabolism. 2000;49:3&#x2013;8. doi: 10.1016/S0026-0495(00)80077-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0026-0495(00)80077-3</ArticleId><ArticleId IdType="pubmed">10693912</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014;24:R453&#x2013;R462. doi: 10.1016/j.cub.2014.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2014.03.034</ArticleId><ArticleId IdType="pmc">PMC4055301</ArticleId><ArticleId IdType="pubmed">24845678</ArticleId></ArticleIdList></Reference><Reference><Citation>Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys. Acta Mol. Cell Res. 2019;1866:118535. doi: 10.1016/j.bbamcr.2019.118535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2019.118535</ArticleId><ArticleId IdType="pubmed">31446062</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and Long COVID: implications for the benefit of high-dose intravenous vitamin C. Front. Pharm. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Cruz-Enr&#xed;quez J, Rojas-Morales E, Ru&#xed;z-Garc&#xed;a MG, Tob&#xf3;n-Velasco JC, Jim&#xe9;nez-Ortega JC. SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients. Free Radic. Res. 2021;55:982&#x2013;995. doi: 10.1080/10715762.2021.2005247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2021.2005247</ArticleId><ArticleId IdType="pubmed">34866537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Mamun A, Dominic A, Le N-T. SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front. Physiol. 2020;11:605908. doi: 10.3389/fphys.2020.605908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605908</ArticleId><ArticleId IdType="pmc">PMC7844210</ArticleId><ArticleId IdType="pubmed">33519510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin. Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108427</ArticleId><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremese E, Ferraccioli G. The pathogenesis of microthrombi in COVID-19 cannot be controlled by DOAC: NETosis should be the target. J. Intern. Med. 2021;289:420&#x2013;421. doi: 10.1111/joim.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13228</ArticleId><ArticleId IdType="pmc">PMC8014777</ArticleId><ArticleId IdType="pubmed">33423337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38:1504&#x2013;1507. doi: 10.1016/j.ajem.2020.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody WE, et al. Persisting adverse ventricular remodeling in COVID-19 survivors: a longitudinal echocardiographic study. J. Am. Soc. Echocardiogr. 2021;34:562&#x2013;566. doi: 10.1016/j.echo.2021.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2021.01.020</ArticleId><ArticleId IdType="pmc">PMC8008825</ArticleId><ArticleId IdType="pubmed">33539950</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieff MG, Feldman EL, Stino AM. Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection. Neurobiol. Dis. 2022;168:105715. doi: 10.1016/j.nbd.2022.105715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105715</ArticleId><ArticleId IdType="pmc">PMC8963977</ArticleId><ArticleId IdType="pubmed">35364273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends Cardiovasc. Med. 2022;32:323&#x2013;330. doi: 10.1016/j.tcm.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9022395</ArticleId><ArticleId IdType="pubmed">35461991</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Kempuraj D. Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID. Cells. 2023;12:688. doi: 10.3390/cells12050688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu AS, Clemens RA. No smell, no taste&#x2014;dealing with a &#x201c;senseless&#x201d; phase of the pandemic: nutritional management of COVID-19 and postacute sequelae of COVID-19. Nutr. Today. 2022;57:309&#x2013;316. doi: 10.1097/NT.0000000000000574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NT.0000000000000574</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisicaro F, et al. Neurological sequelae in patients with COVID-19: a histopathological perspective. Int J. Environ. Res. Public Health. 2021;18:1415. doi: 10.3390/ijerph18041415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041415</ArticleId><ArticleId IdType="pmc">PMC7913756</ArticleId><ArticleId IdType="pubmed">33546463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E, et al. Multifactorial white matter damage in the acute phase and pre-existing conditions may drive cognitive dysfunction after SARS-CoV-2 infection: neuropathology-based evidence. Viruses. 2023;15:908. doi: 10.3390/v15040908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040908</ArticleId><ArticleId IdType="pmc">PMC10144140</ArticleId><ArticleId IdType="pubmed">37112888</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 2023;14:983. doi: 10.1038/s41467-023-36223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, de B Cardoso CR. Microbiota modulation of the gut-lung axis in COVID-19. Front. Immunol. 2021;12:635471. doi: 10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Badi S, et al. From the role of microbiota in gut-lung axis to SARS-CoV-2 pathogenesis. Mediators Inflamm. 2021;2021:6611222. doi: 10.1155/2021/6611222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6611222</ArticleId><ArticleId IdType="pmc">PMC8059477</ArticleId><ArticleId IdType="pubmed">33953641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumlertgul N, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann. Intensive Care. 2021;11:123. doi: 10.1186/s13613-021-00914-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00914-5</ArticleId><ArticleId IdType="pmc">PMC8343342</ArticleId><ArticleId IdType="pubmed">34357478</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm G, et al. OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases. Commun. Biol. 2023;6:22. doi: 10.1038/s42003-022-04303-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-04303-x</ArticleId><ArticleId IdType="pmc">PMC9837150</ArticleId><ArticleId IdType="pubmed">36635485</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, et al. Mast cell activation symptoms are prevalent in Long-COVID. Int J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Wang Z, Abdel-Mohsen M, Chen X, Montaner LJ. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. J. Leukoc. Biol. 2023;113:236&#x2013;254. doi: 10.1093/jleuko/qiac001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiac001</ArticleId><ArticleId IdType="pubmed">36807444</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front. Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542&#x2013;556.e5. doi: 10.1016/j.immuni.2022.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J. Infect. Dis. 2020;221:1762&#x2013;1769. doi: 10.1093/infdis/jiaa150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa150</ArticleId><ArticleId IdType="pmc">PMC7184346</ArticleId><ArticleId IdType="pubmed">32227123</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Becerril B, et al. Immunothrombosis in COVID-19: implications of neutrophil extracellular traps. Biomolecules. 2021;11:694. doi: 10.3390/biom11050694.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11050694</ArticleId><ArticleId IdType="pmc">PMC8148218</ArticleId><ArticleId IdType="pubmed">34066385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243&#x2013;6261.e27. doi: 10.1016/j.cell.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A, et al. Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals. Sci. Rep. 2021;11:20254. doi: 10.1038/s41598-021-99705-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99705-y</ArticleId><ArticleId IdType="pmc">PMC8511073</ArticleId><ArticleId IdType="pubmed">34642411</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, et al. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur. Respir. J. 2023;61:2202226. doi: 10.1183/13993003.02226-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F, et al. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved. Cytokine Growth Factor Rev. 2021;58:82&#x2013;91. doi: 10.1016/j.cytogfr.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7837329</ArticleId><ArticleId IdType="pubmed">33573850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108:17&#x2013;41. doi: 10.1002/JLB.3COVR0520-272R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3COVR0520-272R</ArticleId><ArticleId IdType="pmc">PMC7323250</ArticleId><ArticleId IdType="pubmed">32534467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect. Dis. 2021;8:ofab156. doi: 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun. Rev. 2020;19:102695. doi: 10.1016/j.autrev.2020.102695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102695</ArticleId><ArticleId IdType="pmc">PMC7598743</ArticleId><ArticleId IdType="pubmed">33130000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiv. (Engl. Ed.) 2021;45:96&#x2013;103. doi: 10.1016/j.medin.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7474921</ArticleId><ArticleId IdType="pubmed">38620408</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango M-T, et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol. Res. 2017;65:82&#x2013;98. doi: 10.1007/s12026-016-8817-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8817-7</ArticleId><ArticleId IdType="pubmed">27435705</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G, et al. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2. N. Engl. J. Med. 2020;382:2574&#x2013;2576. doi: 10.1056/NEJMc2009191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771&#x2013;1778. doi: 10.1016/S0140-6736(20)31103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31103-X</ArticleId><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. 2021;20:102792. doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, et al. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, et al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J. Infect. Dis. 2022;225:2155&#x2013;2162. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar A, et al. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2. Trends Mol. Med. 2021;27:1115&#x2013;1134. doi: 10.1016/j.molmed.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8492747</ArticleId><ArticleId IdType="pubmed">34756546</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D, et al. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 2022;14:2031840. doi: 10.1080/19490976.2022.2031840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2031840</ArticleId><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol. Sin. 2020;35:793&#x2013;802. doi: 10.1007/s12250-020-00308-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7644793</ArticleId><ArticleId IdType="pubmed">33156486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, et al. Prolonged impairment of short-chain fatty acid and l-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. 2022;162:548&#x2013;561.e4. doi: 10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna S, Baindara P, Mandal SM. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J. Infect. Public Health. 2020;13:1397&#x2013;1404. doi: 10.1016/j.jiph.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359806</ArticleId><ArticleId IdType="pubmed">32712106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Rev. Med. Virol. 2021;31:1&#x2013;13. doi: 10.1002/rmv.2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2211</ArticleId><ArticleId IdType="pmc">PMC7995004</ArticleId><ArticleId IdType="pubmed">34546607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea L, Neme&#x15f; S-A, Szabo K, Teleky B-E, Vodnar D-C. Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front. Med. (Lausanne) 2022;9:813204. doi: 10.3389/fmed.2022.813204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.813204</ArticleId><ArticleId IdType="pmc">PMC9009523</ArticleId><ArticleId IdType="pubmed">35433746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, et al. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 2022;20:24. doi: 10.1186/s12916-021-02212-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C, et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am. J. Gastroenterol. 2020;115:916&#x2013;923. doi: 10.14309/ajg.0000000000000664.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000664</ArticleId><ArticleId IdType="pmc">PMC7172493</ArticleId><ArticleId IdType="pubmed">32301761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancona G, et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front. Immunol. 2023;14:1080043. doi: 10.3389/fimmu.2023.1080043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1080043</ArticleId><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="pubmed">36969243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, et al. Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilpert K, Mikut R. Is there a connection between gut microbiome dysbiosis occurring in COVID-19 patients and post-COVID-19 symptoms? Front. Microbiol. 2021;12:732838. doi: 10.3389/fmicb.2021.732838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.732838</ArticleId><ArticleId IdType="pmc">PMC8485028</ArticleId><ArticleId IdType="pubmed">34603261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Junior AS, et al. Detection of intestinal dysbiosis in post-COVID-19 patients one to eight months after acute disease resolution. Int J. Environ. Res. Public Health. 2022;19:10189. doi: 10.3390/ijerph191610189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610189</ArticleId><ArticleId IdType="pmc">PMC9408204</ArticleId><ArticleId IdType="pubmed">36011823</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J. Gastroenterol. 2021;27:7925&#x2013;7942. doi: 10.3748/wjg.v27.i46.7925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i46.7925</ArticleId><ArticleId IdType="pmc">PMC8678818</ArticleId><ArticleId IdType="pubmed">35046621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin. Infect. Dis. 2020;71:2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J. Virol. 2023;12:68&#x2013;90. doi: 10.5501/wjv.v12.i2.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v12.i2.68</ArticleId><ArticleId IdType="pmc">PMC10075050</ArticleId><ArticleId IdType="pubmed">37033148</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L-A, et al. Mechanisms leading to gut dysbiosis in COVID-19: current evidence and uncertainties based on adverse outcome pathways. J. Clin. Med. 2022;11:5400. doi: 10.3390/jcm11185400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185400</ArticleId><ArticleId IdType="pmc">PMC9505288</ArticleId><ArticleId IdType="pubmed">36143044</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Bielsa A, et al. COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation. Bras. Dermatol. 2023;98:347&#x2013;354. doi: 10.1016/j.abd.2022.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abd.2022.09.004</ArticleId><ArticleId IdType="pmc">PMC9915050</ArticleId><ArticleId IdType="pubmed">36803914</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009;138:30&#x2013;50. doi: 10.1016/j.cell.2009.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.06.036</ArticleId><ArticleId IdType="pubmed">19596234</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, et al. Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis. Rev. Med. Virol. 2023;33:e2437. doi: 10.1002/rmv.2437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2437</ArticleId><ArticleId IdType="pubmed">36880642</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Song J, Dai L, Post SR, Qin Z. SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era? J. Med. Virol. 2022;94:5103&#x2013;5111. doi: 10.1002/jmv.27994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27994</ArticleId><ArticleId IdType="pmc">PMC9350099</ArticleId><ArticleId IdType="pubmed">35819034</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M, et al. T-cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of coronavirus disease 2019. J. Infect. Dis. 2020;222:198&#x2013;202. doi: 10.1093/infdis/jiaa252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa252</ArticleId><ArticleId IdType="pmc">PMC7239156</ArticleId><ArticleId IdType="pubmed">32379887</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugawara-Mikami M, et al. Skin manifestations of suspected COVID-19: complications of the disease or reactivation of latent viral infections? JAAD Case Rep. 2021;12:15&#x2013;17. doi: 10.1016/j.jdcr.2021.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2021.03.032</ArticleId><ArticleId IdType="pmc">PMC7997159</ArticleId><ArticleId IdType="pubmed">33816732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. Commun. Biol. 2021;4:682. doi: 10.1038/s42003-021-02220-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02220-z</ArticleId><ArticleId IdType="pmc">PMC8175744</ArticleId><ArticleId IdType="pubmed">34083759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Dai L, Kendrick S, Post SR, Qin Z. The anti-COVID-19 drug remdesivir promotes oncogenic herpesvirus reactivation through regulation of intracellular signaling pathways. Antimicrob. Agents Chemother. 2022;66:e0239521. doi: 10.1128/aac.02395-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.02395-21</ArticleId><ArticleId IdType="pmc">PMC8923226</ArticleId><ArticleId IdType="pubmed">35041508</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n Casas C, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br. J. Dermatol. 2020;183:71&#x2013;77. doi: 10.1111/bjd.19163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19163</ArticleId><ArticleId IdType="pmc">PMC7267236</ArticleId><ArticleId IdType="pubmed">32348545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubiche T, Le Duff F, Chiaverini C, Giordanengo V, Passeron T. Negative SARS-CoV-2 PCR in patients with chilblain-like lesions. Lancet Infect. Dis. 2021;21:315&#x2013;316. doi: 10.1016/S1473-3099(20)30518-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30518-1</ArticleId><ArticleId IdType="pmc">PMC7302762</ArticleId><ArticleId IdType="pubmed">32563281</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19. J. Med. Virol. 2021;93:1850&#x2013;1851. doi: 10.1002/jmv.26549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26549</ArticleId><ArticleId IdType="pmc">PMC7537064</ArticleId><ArticleId IdType="pubmed">32970319</ArticleId></ArticleIdList></Reference><Reference><Citation>Naendrup J-H, et al. Reactivation of EBV and CMV in severe COVID-19-epiphenomena or trigger of hyperinflammation in need of treatment? a large case series of critically ill patients. J. Intensive Care Med. 2022;37:1152&#x2013;1158. doi: 10.1177/08850666211053990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666211053990</ArticleId><ArticleId IdType="pmc">PMC9396115</ArticleId><ArticleId IdType="pubmed">34791940</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, et al. High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: immunological findings. PLoS ONE. 2021;16:e0254129. doi: 10.1371/journal.pone.0254129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254129</ArticleId><ArticleId IdType="pmc">PMC8248692</ArticleId><ArticleId IdType="pubmed">34197543</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci. Rep. 2021;11:10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, et al. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect. Dis. 2021;21:955. doi: 10.1186/s12879-021-06638-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06638-y</ArticleId><ArticleId IdType="pmc">PMC8441951</ArticleId><ArticleId IdType="pubmed">34525962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannestad U, et al. Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosa. Front. Med. (Lausanne) 2023;10:1208181. doi: 10.3389/fmed.2023.1208181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1208181</ArticleId><ArticleId IdType="pmc">PMC10349329</ArticleId><ArticleId IdType="pubmed">37457558</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: a proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. 2022;43:187&#x2013;193. doi: 10.2500/aap.2022.43.220018.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, RECOVER Mechanistic Pathways Task Force. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar AAR, et al. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection. Front. Immunol. 2023;14:1147549. doi: 10.3389/fimmu.2023.1147549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1147549</ArticleId><ArticleId IdType="pmc">PMC10176965</ArticleId><ArticleId IdType="pubmed">37187756</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl Acad. Sci. USA. 2020;117:25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ. Res. 2021;128:1323&#x2013;1326. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>DeOre BJ, Tran KA, Andrews AM, Ramirez SH, Galie PA. SARS-CoV-2 spike protein disrupts blood-brain barrier integrity via RhoA activation. J. Neuroimmune Pharm. 2021;16:722&#x2013;728. doi: 10.1007/s11481-021-10029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10029-0</ArticleId><ArticleId IdType="pmc">PMC8536479</ArticleId><ArticleId IdType="pubmed">34687399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubbe L, Cozier GE, Oosthuizen D, Acharya KR, Sturrock ED. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Clin. Sci. (Lond.) 2020;134:2851&#x2013;2871. doi: 10.1042/CS20200899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200899</ArticleId><ArticleId IdType="pmc">PMC7642307</ArticleId><ArticleId IdType="pubmed">33146371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata-Yoshikawa N, et al. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J. Virol. 2019;93:e01815&#x2013;e01818. doi: 10.1128/JVI.01815-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01815-18</ArticleId><ArticleId IdType="pmc">PMC6401451</ArticleId><ArticleId IdType="pubmed">30626688</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study. EClinicalMedicine. 2020;23:100375. doi: 10.1016/j.eclinm.2020.100375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100375</ArticleId><ArticleId IdType="pmc">PMC7196382</ArticleId><ArticleId IdType="pubmed">32368728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system. Hypertension. 2016;68:365&#x2013;377. doi: 10.1161/HYPERTENSIONAHA.115.06892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.06892</ArticleId><ArticleId IdType="pubmed">27217402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert DW, et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2) J. Biol. Chem. 2005;280:30113&#x2013;30119. doi: 10.1074/jbc.M505111200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505111200</ArticleId><ArticleId IdType="pmc">PMC8062222</ArticleId><ArticleId IdType="pubmed">15983030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler SP, Rowe TM, Gomos JB, Kessler PM, Sen GC. Physiological non-equivalence of the two isoforms of angiotensin-converting enzyme. J. Biol. Chem. 2000;275:26259&#x2013;26264. doi: 10.1074/jbc.M004006200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M004006200</ArticleId><ArticleId IdType="pubmed">10831599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagaman JR, et al. Angiotensin-converting enzyme and male fertility. Proc. Natl Acad. Sci. USA. 1998;95:2552&#x2013;2557. doi: 10.1073/pnas.95.5.2552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.5.2552</ArticleId><ArticleId IdType="pmc">PMC19410</ArticleId><ArticleId IdType="pubmed">9482924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs S, et al. Male fertility is dependent on dipeptidase activity of testis ACE. Nat. Med. 2005;11:1140&#x2013;1142. doi: 10.1038/nm1105-1140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1105-1140</ArticleId><ArticleId IdType="pubmed">16270063</ArticleId></ArticleIdList></Reference><Reference><Citation>Erd&#xf6;s EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension. 1990;16:363&#x2013;370. doi: 10.1161/01.HYP.16.4.363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.16.4.363</ArticleId><ArticleId IdType="pubmed">2170273</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis SR, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238&#x2013;33243. doi: 10.1074/jbc.M002615200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000;87:E1&#x2013;E9. doi: 10.1161/01.RES.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am. J. Physiol. Heart Circ. Physiol. 2020;318:H1084&#x2013;H1090. doi: 10.1152/ajpheart.00217.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00217.2020</ArticleId><ArticleId IdType="pmc">PMC7191628</ArticleId><ArticleId IdType="pubmed">32228252</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel VB, Zhong J-C, Grant MB, Oudit GY. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ. Res. 2016;118:1313&#x2013;1326. doi: 10.1161/CIRCRESAHA.116.307708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.307708</ArticleId><ArticleId IdType="pmc">PMC4939482</ArticleId><ArticleId IdType="pubmed">27081112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198:867&#x2013;877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousif MHM, et al. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes. Pharm. Res. 2012;66:269&#x2013;275. doi: 10.1016/j.phrs.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2012.05.001</ArticleId><ArticleId IdType="pubmed">22580236</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu M-J, Yang J-K, Lin S-S, Ji X-J, Guo L-M. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine. 2008;34:56&#x2013;61. doi: 10.1007/s12020-008-9110-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-008-9110-x</ArticleId><ArticleId IdType="pubmed">18956256</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J-K, et al. Interactions among related genes of renin-angiotensin system associated with type 2 diabetes. Diabetes Care. 2010;33:2271&#x2013;2273. doi: 10.2337/dc10-0349.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-0349</ArticleId><ArticleId IdType="pmc">PMC2945173</ArticleId><ArticleId IdType="pubmed">20592051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res. Clin. Pr. 2020;162:108142. doi: 10.1016/j.diabres.2020.108142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108142</ArticleId><ArticleId IdType="pmc">PMC7144611</ArticleId><ArticleId IdType="pubmed">32278764</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams VR, Scholey JW. Angiotensin-converting enzyme 2 and renal disease. Curr. Opin. Nephrol. Hypertens. 2018;27:35&#x2013;41. doi: 10.1097/MNH.0000000000000378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000378</ArticleId><ArticleId IdType="pubmed">29045335</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenina N, Bader M. ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models. Neurochem Res. 2019;44:1323&#x2013;1329. doi: 10.1007/s11064-018-2679-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2679-4</ArticleId><ArticleId IdType="pmc">PMC7089194</ArticleId><ArticleId IdType="pubmed">30443713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahara M, et al. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Cardiovasc. Res. 2014;101:236&#x2013;246. doi: 10.1093/cvr/cvt245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvt245</ArticleId><ArticleId IdType="pubmed">24193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W, et al. Neuropilin-1 mediates SARS-CoV-2 infection of astrocytes in brain organoids, inducing inflammation leading to dysfunction and death of neurons. mBio. 2022;13:e0230822. doi: 10.1128/mbio.02308-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02308-22</ArticleId><ArticleId IdType="pmc">PMC9765283</ArticleId><ArticleId IdType="pubmed">36314791</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman JL, Sayers J, Chapman C, Pellet-Many C. Emerging roles for neuropilin-2 in cardiovascular disease. Int J. Mol. Sci. 2020;21:5154. doi: 10.3390/ijms21145154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145154</ArticleId><ArticleId IdType="pmc">PMC7404143</ArticleId><ArticleId IdType="pubmed">32708258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuckran CA, Liu C, Bruno TC, Workman CJ, Vignali DA. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. J. Immunother. Cancer. 2020;8:e000967. doi: 10.1136/jitc-2020-000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-000967</ArticleId><ArticleId IdType="pmc">PMC7368550</ArticleId><ArticleId IdType="pubmed">32675311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Ch&#xe9;dotal A, He Z, Goodman CS, Tessier-Lavigne M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but Not Sema III. Neuron. 1997;19:547&#x2013;559. doi: 10.1016/S0896-6273(00)80371-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80371-2</ArticleId><ArticleId IdType="pubmed">9331348</ArticleId></ArticleIdList></Reference><Reference><Citation>Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735&#x2013;745. doi: 10.1016/S0092-8674(00)81402-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81402-6</ArticleId><ArticleId IdType="pubmed">9529250</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics. 2000;70:211&#x2013;222. doi: 10.1006/geno.2000.6381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.2000.6381</ArticleId><ArticleId IdType="pubmed">11112349</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H-F, Vander Kooi CW. Neuropilin functions as an essential cell surface receptor. J. Biol. Chem. 2015;290:29120&#x2013;29126. doi: 10.1074/jbc.R115.687327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R115.687327</ArticleId><ArticleId IdType="pmc">PMC4705917</ArticleId><ArticleId IdType="pubmed">26451046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou A, Ruhrberg C. Neuropilin regulation of angiogenesis. Biochem Soc. Trans. 2014;42:1623&#x2013;1628. doi: 10.1042/BST20140244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20140244</ArticleId><ArticleId IdType="pubmed">25399580</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenburg S, Schulz A, Poitz DM, Muders MH. Role of neuropilin-2 in the immune system. Mol. Immunol. 2017;90:239&#x2013;244. doi: 10.1016/j.molimm.2017.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2017.08.010</ArticleId><ArticleId IdType="pubmed">28843905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzolio S, Tamagnone L. Multifaceted role of neuropilins in cancer. Curr. Med Chem. 2011;18:3563&#x2013;3575. doi: 10.2174/092986711796642544.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986711796642544</ArticleId><ArticleId IdType="pubmed">21756227</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, et al. Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy. Front. Immunol. 2017;8:1228. doi: 10.3389/fimmu.2017.01228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01228</ArticleId><ArticleId IdType="pmc">PMC5641316</ArticleId><ArticleId IdType="pubmed">29067024</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Miller S, et al. Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry. ACS Chem. Neurosci. 2021;12:1299&#x2013;1312. doi: 10.1021/acschemneuro.0c00619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00619</ArticleId><ArticleId IdType="pmc">PMC8029449</ArticleId><ArticleId IdType="pubmed">33787218</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutal A, et al. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain. 2021;162:243&#x2013;252. doi: 10.1097/j.pain.0000000000002097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002097</ArticleId><ArticleId IdType="pmc">PMC7737878</ArticleId><ArticleId IdType="pubmed">33009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues A, Fantin A. Neuropilin 1 regulation of vascular permeability signaling. Biomolecules. 2021;11:666. doi: 10.3390/biom11050666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11050666</ArticleId><ArticleId IdType="pmc">PMC8146136</ArticleId><ArticleId IdType="pubmed">33947161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaji M, Mahmoud M, Evans IM, Zachary IC. Neuropilin 1 is essential for gastrointestinal smooth muscle contractility and motility in aged mice. PLoS ONE. 2015;10:e0115563. doi: 10.1371/journal.pone.0115563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115563</ArticleId><ArticleId IdType="pmc">PMC4319892</ArticleId><ArticleId IdType="pubmed">25659123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontarollo G, et al. Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling. Nat. Metab. 2023;5:1174&#x2013;1187. doi: 10.1038/s42255-023-00828-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-023-00828-5</ArticleId><ArticleId IdType="pmc">PMC10365997</ArticleId><ArticleId IdType="pubmed">37414930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, et al. Neuropilin-1-mediated SARS-CoV-2 infection in bone marrow-derived macrophages inhibits osteoclast differentiation. Adv. Biol. (Weinh.) 2022;6:e2200007. doi: 10.1002/adbi.202200007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.202200007</ArticleId><ArticleId IdType="pmc">PMC9073998</ArticleId><ArticleId IdType="pubmed">35195371</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104742</ArticleId><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise RJ, et al. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc. Natl Acad. Sci. USA. 1990;87:9378&#x2013;9382. doi: 10.1073/pnas.87.23.9378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.23.9378</ArticleId><ArticleId IdType="pmc">PMC55168</ArticleId><ArticleId IdType="pubmed">2251280</ArticleId></ArticleIdList></Reference><Reference><Citation>Duckert P, Brunak S, Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 2004;17:107&#x2013;112. doi: 10.1093/protein/gzh013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/gzh013</ArticleId><ArticleId IdType="pubmed">14985543</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun E, Sauter D. Furin-mediated protein processing in infectious diseases and cancer. Clin. Transl. Immunol. 2019;8:e1073. doi: 10.1002/cti2.1073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1073</ArticleId><ArticleId IdType="pmc">PMC6682551</ArticleId><ArticleId IdType="pubmed">31406574</ArticleId></ArticleIdList></Reference><Reference><Citation>Klenk HD, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 1994;2:39&#x2013;43. doi: 10.1016/0966-842X(94)90123-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0966-842X(94)90123-6</ArticleId><ArticleId IdType="pubmed">8162439</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Huajun W, Wu J. Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases. Sci. Rep. 2012;2:261. doi: 10.1038/srep00261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00261</ArticleId><ArticleId IdType="pmc">PMC3281273</ArticleId><ArticleId IdType="pubmed">22355773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Huang Q, Fang Y, Wu J. FurinDB: a database of 20-residue furin cleavage site motifs, substrates and their associated drugs. Int J. Mol. Sci. 2011;12:1060&#x2013;1065. doi: 10.3390/ijms12021060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms12021060</ArticleId><ArticleId IdType="pmc">PMC3083689</ArticleId><ArticleId IdType="pubmed">21541042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 2002;3:753&#x2013;766. doi: 10.1038/nrm934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm934</ArticleId><ArticleId IdType="pmc">PMC1964754</ArticleId><ArticleId IdType="pubmed">12360192</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DP, et al. Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J. Biol. Chem. 1990;265:20673&#x2013;20677. doi: 10.1016/S0021-9258(17)30556-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)30556-2</ArticleId><ArticleId IdType="pubmed">2243114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata M, Fryling CM, Pastan I, FitzGerald DJ. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem. 1992;267:25396&#x2013;25401. doi: 10.1016/S0021-9258(19)74054-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)74054-X</ArticleId><ArticleId IdType="pubmed">1460035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuneoka M, et al. Evidence for involvement of furin in cleavage and activation of diphtheria toxin. J. Biol. Chem. 1993;268:26461&#x2013;26465. doi: 10.1016/S0021-9258(19)74337-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)74337-3</ArticleId><ArticleId IdType="pubmed">8253774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon VM, Leppla SH. Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect. Immun. 1994;62:333&#x2013;340. doi: 10.1128/iai.62.2.333-340.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.62.2.333-340.1994</ArticleId><ArticleId IdType="pmc">PMC186112</ArticleId><ArticleId IdType="pubmed">8300195</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddington RC. Assembly and function of the anthrax toxin protein translocation complex. Subcell. Biochem. 2021;96:563&#x2013;577. doi: 10.1007/978-3-030-58971-4_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-58971-4_18</ArticleId><ArticleId IdType="pubmed">33252744</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J. Biol. Chem. 1992;267:16396&#x2013;16402. doi: 10.1016/S0021-9258(18)42016-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)42016-9</ArticleId><ArticleId IdType="pubmed">1644824</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z-W, Ma Q, Liu J, Li J-W, Chen Y-D. The association between plasma furin and cardiovascular events after acute myocardial infarction. BMC Cardiovasc. Disord. 2021;21:468. doi: 10.1186/s12872-021-02029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-021-02029-y</ArticleId><ArticleId IdType="pmc">PMC8477572</ArticleId><ArticleId IdType="pubmed">34579647</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupays L, et al. Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function. PLoS ONE. 2019;14:e0212992. doi: 10.1371/journal.pone.0212992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212992</ArticleId><ArticleId IdType="pmc">PMC6402701</ArticleId><ArticleId IdType="pubmed">30840660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S, et al. Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway. Dig. Liver Dis. 2021;53:1276&#x2013;1285. doi: 10.1016/j.dld.2021.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2021.02.011</ArticleId><ArticleId IdType="pubmed">33640301</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies. Front. Genet. 2023;14:1187985. doi: 10.3389/fgene.2023.1187985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2023.1187985</ArticleId><ArticleId IdType="pmc">PMC10250669</ArticleId><ArticleId IdType="pubmed">37303950</ArticleId></ArticleIdList></Reference><Reference><Citation>Remacle AG, Rozanov DV, Fugere M, Day R, Strongin AY. Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP. Oncogene. 2006;25:5648&#x2013;5655. doi: 10.1038/sj.onc.1209572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209572</ArticleId><ArticleId IdType="pubmed">16636666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, et al. Inhibition of furin results in increased growth, invasiveness and cytokine production of synoviocytes from patients with rheumatoid arthritis. Jt. Bone Spine. 2017;84:433&#x2013;439. doi: 10.1016/j.jbspin.2016.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2016.05.017</ArticleId><ArticleId IdType="pubmed">27450196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. The emerging role of furin in neurodegenerative and neuropsychiatric diseases. Transl. Neurodegener. 2022;11:39. doi: 10.1186/s40035-022-00313-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00313-1</ArticleId><ArticleId IdType="pmc">PMC9395820</ArticleId><ArticleId IdType="pubmed">35996194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WY, Mok A, Chung JPW. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review. Hong. Kong Med J. 2021;27:118&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">33853972</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L-Y, et al. Placenta-specific 1 regulates oocyte meiosis and fertilization through furin. FASEB J. 2018;32:5483&#x2013;5494. doi: 10.1096/fj.201700922RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700922RR</ArticleId><ArticleId IdType="pubmed">29723063</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T-G, et al. Oocyte-specific deletion of furin leads to female infertility by causing early secondary follicle arrest in mice. Cell Death Dis. 2017;8:e2846. doi: 10.1038/cddis.2017.231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.231</ArticleId><ArticleId IdType="pmc">PMC5520891</ArticleId><ArticleId IdType="pubmed">28569793</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser BJ, et al. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation. Nat. Chem. Biol. 2022;18:963&#x2013;971. doi: 10.1038/s41589-022-01059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-022-01059-7</ArticleId><ArticleId IdType="pubmed">35676539</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch J, et al. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J. 2021;40:e107821. doi: 10.15252/embj.2021107821.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107821</ArticleId><ArticleId IdType="pmc">PMC8365257</ArticleId><ArticleId IdType="pubmed">34159616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-W, et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am. J. Pathol. 2010;176:2986&#x2013;2996. doi: 10.2353/ajpath.2010.090665.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090665</ArticleId><ArticleId IdType="pmc">PMC2877858</ArticleId><ArticleId IdType="pubmed">20382709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin B, et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 1999;59:4180&#x2013;4184.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485450</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler BA, et al. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. J. Clin. Invest. 2021;131:e140766. doi: 10.1172/JCI140766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140766</ArticleId><ArticleId IdType="pmc">PMC7773394</ArticleId><ArticleId IdType="pubmed">33180746</ArticleId></ArticleIdList></Reference><Reference><Citation>Thunders M, Delahunt B. Gene of the month: TMPRSS2 (transmembrane serine protease 2) J. Clin. Pathol. 2020;73:773&#x2013;776. doi: 10.1136/jclinpath-2020-206987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206987</ArticleId><ArticleId IdType="pubmed">32873700</ArticleId></ArticleIdList></Reference><Reference><Citation>List K, et al. Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am. J. Pathol. 2009;175:1453&#x2013;1463. doi: 10.2353/ajpath.2009.090240.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090240</ArticleId><ArticleId IdType="pmc">PMC2751542</ArticleId><ArticleId IdType="pubmed">19717635</ArticleId></ArticleIdList></Reference><Reference><Citation>Antalis TM, Bugge TH, Wu Q. Membrane-anchored serine proteases in health and disease. Prog. Mol. Biol. Transl. Sci. 2011;99:1&#x2013;50. doi: 10.1016/B978-0-12-385504-6.00001-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385504-6.00001-4</ArticleId><ArticleId IdType="pmc">PMC3697097</ArticleId><ArticleId IdType="pubmed">21238933</ArticleId></ArticleIdList></Reference><Reference><Citation>Heurich A, et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 2014;88:1293&#x2013;1307. doi: 10.1128/JVI.02202-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02202-13</ArticleId><ArticleId IdType="pmc">PMC3911672</ArticleId><ArticleId IdType="pubmed">24227843</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai S, et al. Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis. Hum. Cell. 2015;28:44&#x2013;50. doi: 10.1007/s13577-014-0101-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-014-0101-3</ArticleId><ArticleId IdType="pmc">PMC4286132</ArticleId><ArticleId IdType="pubmed">25186085</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquinet E, Rao NV, Rao GV, Hoidal JR. Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Lett. 2000;468:93&#x2013;100. doi: 10.1016/S0014-5793(00)01196-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)01196-0</ArticleId><ArticleId IdType="pubmed">10683448</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Li S, Zhang X, Dong N. Type II transmembrane serine proteases as modulators in adipose tissue phenotype and function. Biomedicines. 2023;11:1794. doi: 10.3390/biomedicines11071794.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071794</ArticleId><ArticleId IdType="pmc">PMC10376093</ArticleId><ArticleId IdType="pubmed">37509434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam DK, Dang D, Flynn AN, Hardt M, Schmidt BL. TMPRSS2, a novel membrane-anchored mediator in cancer pain. Pain. 2015;156:923&#x2013;930. doi: 10.1097/j.pain.0000000000000130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000130</ArticleId><ArticleId IdType="pmc">PMC5215063</ArticleId><ArticleId IdType="pubmed">25734995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunne S, et al. TMPRSS2 impacts cytokine expression in murine dendritic cells. Biomedicines. 2023;11:419. doi: 10.3390/biomedicines11020419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020419</ArticleId><ArticleId IdType="pmc">PMC9952936</ArticleId><ArticleId IdType="pubmed">36830955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeginiadou T, Symeonidis EN, Symeonidis A, Vakalopoulos I. SARS-CoV-2 infection (COVID-19) and male fertility: Something we should be worried about? Urologia. 2023;90:726&#x2013;734. doi: 10.1177/03915603231175941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03915603231175941</ArticleId><ArticleId IdType="pmc">PMC10247691</ArticleId><ArticleId IdType="pubmed">37278004</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. COVID-19 and male reproduction: a thorny problem. Am. J. Mens. Health. 2022;16:15579883221074816. doi: 10.1177/15579883221074816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15579883221074816</ArticleId><ArticleId IdType="pmc">PMC8859685</ArticleId><ArticleId IdType="pubmed">35176914</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CE, List K. Cell surface-anchored serine proteases in cancer progression and metastasis. Cancer Metastasis Rev. 2019;38:357&#x2013;387. doi: 10.1007/s10555-019-09811-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-019-09811-7</ArticleId><ArticleId IdType="pmc">PMC6893142</ArticleId><ArticleId IdType="pubmed">31529338</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, et al. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2. J. Cell Mol. Med. 2021;25:4157&#x2013;4165. doi: 10.1111/jcmm.16385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16385</ArticleId><ArticleId IdType="pmc">PMC8013364</ArticleId><ArticleId IdType="pubmed">33609069</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdowska I, Matusiewicz M. Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract. World J. Gastroenterol. 2021;27:6590&#x2013;6600. doi: 10.3748/wjg.v27.i39.6590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i39.6590</ArticleId><ArticleId IdType="pmc">PMC8554394</ArticleId><ArticleId IdType="pubmed">34754154</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G, et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl Acad. Sci. USA. 2005;102:11876&#x2013;11881. doi: 10.1073/pnas.0505577102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0505577102</ArticleId><ArticleId IdType="pmc">PMC1188015</ArticleId><ArticleId IdType="pubmed">16081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollavaram K, et al. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Protein Sci. 2021;30:1131&#x2013;1143. doi: 10.1002/pro.4073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4073</ArticleId><ArticleId IdType="pmc">PMC8138523</ArticleId><ArticleId IdType="pubmed">33786919</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes CP, et al. Cathepsin L in COVID-19: from pharmacological evidences to genetics. Front. Cell Infect. Microbiol. 2020;10:589505. doi: 10.3389/fcimb.2020.589505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.589505</ArticleId><ArticleId IdType="pmc">PMC7753008</ArticleId><ArticleId IdType="pubmed">33364201</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzdorf K, et al. TMPRSS2 is essential for SARS-CoV-2 beta and omicron infection. Viruses. 2023;15:271. doi: 10.3390/v15020271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020271</ArticleId><ArticleId IdType="pmc">PMC9961888</ArticleId><ArticleId IdType="pubmed">36851486</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 2001;20:4629&#x2013;4633. doi: 10.1093/emboj/20.17.4629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.17.4629</ArticleId><ArticleId IdType="pmc">PMC125585</ArticleId><ArticleId IdType="pubmed">11532926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosnowski P, Turk D. Caught in the act: the crystal structure of cleaved cathepsin L bound to the active site of Cathepsin L. FEBS Lett. 2016;590:1253&#x2013;1261. doi: 10.1002/1873-3468.12140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12140</ArticleId><ArticleId IdType="pubmed">26992470</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson DP. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit. Rev. Oral. Biol. Med. 2002;13:238&#x2013;275. doi: 10.1177/154411130201300304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/154411130201300304</ArticleId><ArticleId IdType="pubmed">12090464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitzel C, et al. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion. FEBS Lett. 2000;485:67&#x2013;70. doi: 10.1016/S0014-5793(00)02189-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)02189-X</ArticleId><ArticleId IdType="pubmed">11086167</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk B, Turk D, Turk V. Protease signalling: the cutting edge. EMBO J. 2012;31:1630&#x2013;1643. doi: 10.1038/emboj.2012.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.42</ArticleId><ArticleId IdType="pmc">PMC3321211</ArticleId><ArticleId IdType="pubmed">22367392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing LC, Rudensky AY. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 2005;207:229&#x2013;241. doi: 10.1111/j.0105-2896.2005.00310.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00310.x</ArticleId><ArticleId IdType="pubmed">16181340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakegawa H, et al. Participation of cathepsin L on bone resorption. FEBS Lett. 1993;321:247&#x2013;250. doi: 10.1016/0014-5793(93)80118-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(93)80118-E</ArticleId><ArticleId IdType="pubmed">8477857</ArticleId></ArticleIdList></Reference><Reference><Citation>Brix K, Lemansky P, Herzog V. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology. 1996;137:1963&#x2013;1974. doi: 10.1210/endo.137.5.8612537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo.137.5.8612537</ArticleId><ArticleId IdType="pubmed">8612537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujishima A, et al. The crystal structure of human cathepsin L complexed with E-64. FEBS Lett. 1997;407:47&#x2013;50. doi: 10.1016/S0014-5793(97)00216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(97)00216-0</ArticleId><ArticleId IdType="pubmed">9141479</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinheckel T, Tholen M. Low-level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleus. FEBS Open Bio. 2022;12:694&#x2013;707. doi: 10.1002/2211-5463.13385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13385</ArticleId><ArticleId IdType="pmc">PMC8972055</ArticleId><ArticleId IdType="pubmed">35203107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezz MA, Takahashi M, Rivera RM, Balboula AZ. Cathepsin L regulates oocyte meiosis and preimplantation embryo development. Cell Prolif. 2024;57:e13526. doi: 10.1111/cpr.13526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.13526</ArticleId><ArticleId IdType="pmc">PMC10771118</ArticleId><ArticleId IdType="pubmed">37417221</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandren N, et al. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Hum. Reprod. 2022;37:1126&#x2013;1133. doi: 10.1093/humrep/deac062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deac062</ArticleId><ArticleId IdType="pmc">PMC9047154</ArticleId><ArticleId IdType="pubmed">35389480</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevali O, Cionna C, Tosti L, Lubzens E, Maradonna F. Role of cathepsins in ovarian follicle growth and maturation. Gen. Comp. Endocrinol. 2006;146:195&#x2013;203. doi: 10.1016/j.ygcen.2005.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygcen.2005.12.007</ArticleId><ArticleId IdType="pubmed">16430893</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a V, et al. Transient expression of progesterone receptor and cathepsin-l in human granulosa cells during the periovulatory period. Fertil. Steril. 2012;97:707&#x2013;713.e1. doi: 10.1016/j.fertnstert.2011.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2011.12.039</ArticleId><ArticleId IdType="pubmed">22281037</ArticleId></ArticleIdList></Reference><Reference><Citation>Funkelstein L, Hook V. The novel role of cathepsin L for neuropeptide production illustrated by research strategies in chemical biology with protease gene knockout and expression. Methods Mol. Biol. 2011;768:107&#x2013;125. doi: 10.1007/978-1-61779-204-5_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-204-5_5</ArticleId><ArticleId IdType="pubmed">21805239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hook VYH. Unique neuronal functions of cathepsin L and cathepsin B in secretory vesicles: biosynthesis of peptides in neurotransmission and neurodegenerative disease. Biol. Chem. 2006;387:1429&#x2013;1439. doi: 10.1515/BC.2006.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2006.179</ArticleId><ArticleId IdType="pubmed">17081116</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Zhang H, Yang X, Qian Y, Xiao Q. Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-&#x3ba;B pathways. Neurobiol. Aging. 2018;62:159&#x2013;167. doi: 10.1016/j.neurobiolaging.2017.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.030</ArticleId><ArticleId IdType="pubmed">29154036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettunen P, et al. SARS-CoV-2 infection of human neurons is TMPRSS2 independent, requires endosomal cell entry, and can be blocked by inhibitors of host phosphoinositol-5 kinase. J. Virol. 2023;97:e0014423. doi: 10.1128/jvi.00144-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00144-23</ArticleId><ArticleId IdType="pmc">PMC10134833</ArticleId><ArticleId IdType="pubmed">37039676</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc. Res. 2020;116:2177&#x2013;2184. doi: 10.1093/cvr/cvaa230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, et al. Critical role of cathepsin L/V in regulating endothelial cell senescence. Biology (Basel) 2022;12:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9855167</ArticleId><ArticleId IdType="pubmed">36671735</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, et al. Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways. J. Am. Heart Assoc. 2013;2:e000191. doi: 10.1161/JAHA.113.000191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000191</ArticleId><ArticleId IdType="pmc">PMC3647266</ArticleId><ArticleId IdType="pubmed">23608608</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L-S, et al. Hypertension exacerbates severity and outcomes of COVID-19 in elderly patients: a retrospective observational study. Curr. Med Sci. 2022;42:561&#x2013;568. doi: 10.1007/s11596-022-2539-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-022-2539-y</ArticleId><ArticleId IdType="pmc">PMC9178941</ArticleId><ArticleId IdType="pubmed">35678917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, et al. Angiotensin II-Induced vascular remodeling and hypertension involves cathepsin L/V- MEK/ERK mediated mechanism. Int J. Cardiol. 2020;298:98&#x2013;106. doi: 10.1016/j.ijcard.2019.09.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.09.070</ArticleId><ArticleId IdType="pubmed">31668507</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, et al. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis. Exp. Dermatol. 2016;25:287&#x2013;292. doi: 10.1111/exd.12920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.12920</ArticleId><ArticleId IdType="pubmed">26661692</ArticleId></ArticleIdList></Reference><Reference><Citation>Manchanda M, et al. Cathepsin L and B as potential markers for liver fibrosis: insights from patients and experimental models. Clin. Transl. Gastroenterol. 2017;8:e99. doi: 10.1038/ctg.2017.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ctg.2017.25</ArticleId><ArticleId IdType="pmc">PMC5518948</ArticleId><ArticleId IdType="pubmed">28617446</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah H, Khan MSH, Dhurandhar NV, Hegde V. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Acta Diabetol. 2021;58:831&#x2013;843. doi: 10.1007/s00592-020-01636-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01636-z</ArticleId><ArticleId IdType="pmc">PMC7882857</ArticleId><ArticleId IdType="pubmed">33587177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, et al. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat. Cell Biol. 2007;9:970&#x2013;977. doi: 10.1038/ncb1623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1623</ArticleId><ArticleId IdType="pubmed">17643114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrona M, Skrypnik D. New-onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection-systematic review. Int J. Environ. Res. Public Health. 2022;19:13280. doi: 10.3390/ijerph192013280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013280</ArticleId><ArticleId IdType="pmc">PMC9602450</ArticleId><ArticleId IdType="pubmed">36293857</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E, et al. Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J. Mol. Sci. 2020;21:8623. doi: 10.3390/ijms21228623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228623</ArticleId><ArticleId IdType="pmc">PMC7696386</ArticleId><ArticleId IdType="pubmed">33207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. Carboxylic submetabolome-driven signature characterization of COVID-19 asymptomatic infection. Talanta. 2022;239:123086. doi: 10.1016/j.talanta.2021.123086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.talanta.2021.123086</ArticleId><ArticleId IdType="pmc">PMC8632795</ArticleId><ArticleId IdType="pubmed">34871866</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, et al. Arginine and endothelial function. Biomedicines. 2020;8:277. doi: 10.3390/biomedicines8080277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8080277</ArticleId><ArticleId IdType="pmc">PMC7460461</ArticleId><ArticleId IdType="pubmed">32781796</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharm. Physiol. 2007;34:906&#x2013;911. doi: 10.1111/j.1440-1681.2007.04638.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2007.04638.x</ArticleId><ArticleId IdType="pmc">PMC1955221</ArticleId><ArticleId IdType="pubmed">17645639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg JO, Weitzberg E. Nitric oxide signaling in health and disease. Cell. 2022;185:2853&#x2013;2878. doi: 10.1016/j.cell.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.010</ArticleId><ArticleId IdType="pubmed">35931019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees CA, et al. Altered amino acid profile in patients with SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA. 2021;118:e2101708118. doi: 10.1073/pnas.2101708118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101708118</ArticleId><ArticleId IdType="pmc">PMC8237604</ArticleId><ArticleId IdType="pubmed">34088793</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944&#x2013;953. doi: 10.1001/jama.286.8.944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.8.944</ArticleId><ArticleId IdType="pubmed">11509059</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, et al. SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J. Clin. Immunol. 2021;41:515&#x2013;525. doi: 10.1007/s10875-020-00920-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A, et al. l-Arginine and COVID-19: an update. Nutrients. 2021;13:3951. doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, et al. Effects of l-arginine plus vitamin c supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021;40:101125. doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, et al. L-Arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic. J. Pharm. Exp. Ther. 2022;381:197&#x2013;203. doi: 10.1124/jpet.122.001149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.122.001149</ArticleId><ArticleId IdType="pmc">PMC9190231</ArticleId><ArticleId IdType="pubmed">35339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes JM, et al. Arginine depletion as a therapeutic approach for patients with COVID-19. Int J. Infect. Dis. 2021;102:566&#x2013;570. doi: 10.1016/j.ijid.2020.10.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.100</ArticleId><ArticleId IdType="pmc">PMC7641537</ArticleId><ArticleId IdType="pubmed">33160064</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, et al. Effects of L-arginine plus vitamin C supplementation on l-arginine metabolism in adults with long COVID: secondary analysis of a randomized clinical trial. Int J. Mol. Sci. 2023;24:5078. doi: 10.3390/ijms24065078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065078</ArticleId><ArticleId IdType="pmc">PMC10049539</ArticleId><ArticleId IdType="pubmed">36982151</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante S, et al. Tryptophan metabolism &#x2018;hub&#x2019; gene expression associates with increased inflammation and severe disease outcomes in COVID-19 infection and inflammatory bowel disease. Int J. Mol. Sci. 2022;23:14776. doi: 10.3390/ijms232314776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314776</ArticleId><ArticleId IdType="pmc">PMC9737535</ArticleId><ArticleId IdType="pubmed">36499104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Azechi H, Board M. Essential role of excessive tryptophan and its neurometabolites in fatigue. Can. J. Neurol. Sci. 2012;39:40&#x2013;47. doi: 10.1017/S031716710001266X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S031716710001266X</ArticleId><ArticleId IdType="pubmed">22384494</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M. Potential role of neuroactive tryptophan metabolites in central fatigue: establishment of the fatigue circuit. Int. J. Tryptophan Res. 2020;13:1178646920936279. doi: 10.1177/1178646920936279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178646920936279</ArticleId><ArticleId IdType="pmc">PMC7325545</ArticleId><ArticleId IdType="pubmed">32647476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;, Ero&#x11f;lu B&#xc7;, G&#xfc;ven GS. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) Nutrition. 2021;90:111308. doi: 10.1016/j.nut.2021.111308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111308</ArticleId><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat A, Pires AS, Tan V, Babu Chidambaram S, Guillemin GJ. Effects of sleep deprivation on the tryptophan metabolism. Int. J. Tryptophan Res. 2020;13:1178646920970902. doi: 10.1177/1178646920970902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178646920970902</ArticleId><ArticleId IdType="pmc">PMC7686593</ArticleId><ArticleId IdType="pubmed">33281456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorgdrager FJH, Naud&#xe9; PJW, Kema IP, Nollen EA, Deyn PPD. Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front. Immunol. 2019;10:2565. doi: 10.3389/fimmu.2019.02565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02565</ArticleId><ArticleId IdType="pmc">PMC6833926</ArticleId><ArticleId IdType="pubmed">31736978</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Khairi Abed A, Rouf Moustafa S, Almulla AF, Maes M. Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID. Front. Mol. Neurosci. 2023;16:1194769. doi: 10.3389/fnmol.2023.1194769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2023.1194769</ArticleId><ArticleId IdType="pmc">PMC10272345</ArticleId><ArticleId IdType="pubmed">37333619</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy AA-B. The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy. Biosci. Rep. 2023;43:BSR20230595. doi: 10.1042/BSR20230595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20230595</ArticleId><ArticleId IdType="pmc">PMC10407158</ArticleId><ArticleId IdType="pubmed">37486805</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakoor H, et al. Be well: a potential role for vitamin B in COVID-19. Maturitas. 2021;144:108&#x2013;111. doi: 10.1016/j.maturitas.2020.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2020.08.007</ArticleId><ArticleId IdType="pmc">PMC7428453</ArticleId><ArticleId IdType="pubmed">32829981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19? Med. Hypotheses. 2021;153:110627. doi: 10.1016/j.mehy.2021.110627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110627</ArticleId><ArticleId IdType="pmc">PMC8180092</ArticleId><ArticleId IdType="pubmed">34139598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalakshmi AM, et al. Alterations in tryptophan metabolism affect vascular functions: connected to ageing population vulnerability to COVID-19 infection? Int. J. Tryptophan Res. 2022;15:11786469221083946. doi: 10.1177/11786469221083946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11786469221083946</ArticleId><ArticleId IdType="pmc">PMC9133873</ArticleId><ArticleId IdType="pubmed">35645571</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachou M, Siamidi A, Dedeloudi A, Konstantinidou SK, Papanastasiou IP. Pineal hormone melatonin as an adjuvant treatment for COVID&#x2011;19 (Review) Int J. Mol. Med. 2021;47:47. doi: 10.3892/ijmm.2021.4880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2021.4880</ArticleId><ArticleId IdType="pmc">PMC7891824</ArticleId><ArticleId IdType="pubmed">33576451</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter RJ, et al. Melatonin inhibits COVID-19-Induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis. Med Drug Discov. 2020;6:100044. doi: 10.1016/j.medidd.2020.100044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medidd.2020.100044</ArticleId><ArticleId IdType="pmc">PMC7211589</ArticleId><ArticleId IdType="pubmed">32395713</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria-Castro R, et al. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin. J. Leukoc. Biol. 2021;110:425&#x2013;431. doi: 10.1002/JLB.4HI0221-087R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4HI0221-087R</ArticleId><ArticleId IdType="pmc">PMC8242632</ArticleId><ArticleId IdType="pubmed">34057753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8:56. doi: 10.3390/nu8010056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8010056</ArticleId><ArticleId IdType="pmc">PMC4728667</ArticleId><ArticleId IdType="pubmed">26805875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi AM, Tanabe A, Iwahori Y. A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning. J. Diet. Suppl. 2021;18:316&#x2013;333. doi: 10.1080/19390211.2020.1746725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2020.1746725</ArticleId><ArticleId IdType="pubmed">32272859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutanto CN, Loh WW, Kim JE. The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutr. Rev. 2022;80:306&#x2013;316. doi: 10.1093/nutrit/nuab027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuab027</ArticleId><ArticleId IdType="pubmed">33942088</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. Am. J. Emerg. Med. 2020;38:1544.e1&#x2013;1544.e3. doi: 10.1016/j.ajem.2020.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC7141630</ArticleId><ArticleId IdType="pubmed">32312574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ya&#x11f;c&#x131; S, Serin E, Acicbe &#xd6;, Zeren M&#x130;, Odaba&#x15f;&#x131; MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int. J. Lab Hematol. 2021;43:142&#x2013;151. doi: 10.1111/ijlh.13479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.13479</ArticleId><ArticleId IdType="pmc">PMC8014125</ArticleId><ArticleId IdType="pubmed">33554466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L, et al. Dynamics in anemia development and dysregulation of iron homeostasis in hospitalized patients with COVID-19. Metabolites. 2021;11:653. doi: 10.3390/metabo11100653.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11100653</ArticleId><ArticleId IdType="pmc">PMC8540370</ArticleId><ArticleId IdType="pubmed">34677368</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J. Mol. Sci. 2017;18:1985. doi: 10.3390/ijms18091985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091985</ArticleId><ArticleId IdType="pmc">PMC5618634</ArticleId><ArticleId IdType="pubmed">28914813</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu, A. S. Natural Food Antimicrobial Systems. (CRC Press, 2000).</Citation></Reference><Reference><Citation>Maneva A, Taleva B, Maneva L. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforsch. C. J. Biosci. 2003;58:256&#x2013;262. doi: 10.1515/znc-2003-3-420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/znc-2003-3-420</ArticleId><ArticleId IdType="pubmed">12710738</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegasothy H, Weerakkody R, Selby-Pham S, Bennett LE. In vitro heme and non-heme iron capture from hemoglobin, myoglobin and ferritin by bovine lactoferrin and implications for suppression of reactive oxygen species in vivo. Biometals. 2014;27:1371&#x2013;1382. doi: 10.1007/s10534-014-9798-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-014-9798-4</ArticleId><ArticleId IdType="pubmed">25280951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:1294&#x2013;1297. doi: 10.1007/s00134-020-06028-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06028-z</ArticleId><ArticleId IdType="pmc">PMC7131986</ArticleId><ArticleId IdType="pubmed">32253449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj S, Naidu TAG, Betageri GV, Prasadarao NV, Naidu AS. Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women. Inflamm. Res. 2010;59:971&#x2013;978. doi: 10.1007/s00011-010-0211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-010-0211-7</ArticleId><ArticleId IdType="pubmed">20473630</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Ng TB, Sun W-Z. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int. J. Antimicrob. Agents. 2020;56:106118. doi: 10.1016/j.ijantimicag.2020.106118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106118</ArticleId><ArticleId IdType="pmc">PMC7390755</ArticleId><ArticleId IdType="pubmed">32738305</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano G, et al. Liposomal lactoferrin as potential preventative and cure for COVID-19. IJRHS. 2020;8:08&#x2013;15. doi: 10.5530/ijrhs.8.1.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.5530/ijrhs.8.1.3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Meng X, Zhang F, Xiang Y, Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg. Microbes Infect. 2021;10:317&#x2013;330. doi: 10.1080/22221751.2021.1888660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1888660</ArticleId><ArticleId IdType="pmc">PMC7919907</ArticleId><ArticleId IdType="pubmed">33560940</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu SAG, et al. COVID-19 during pregnancy and postpartum. J. Diet. Suppl. 2022;19:78&#x2013;114. doi: 10.1080/19390211.2020.1834047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2020.1834047</ArticleId><ArticleId IdType="pubmed">33164606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang G-J, Zhao H. Can SARS-CoV-2-infected women breastfeed after viral clearance? J. Zhejiang Univ. Sci. B. 2020;21:405&#x2013;407. doi: 10.1631/jzus.B2000095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000095</ArticleId><ArticleId IdType="pmc">PMC7205600</ArticleId><ArticleId IdType="pubmed">32425007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrantoni A, et al. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob. Agents Chemother. 2003;47:2688&#x2013;2691. doi: 10.1128/AAC.47.8.2688-2691.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.47.8.2688-2691.2003</ArticleId><ArticleId IdType="pmc">PMC166106</ArticleId><ArticleId IdType="pubmed">12878543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang J, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE. 2011;6:e23710. doi: 10.1371/journal.pone.0023710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023710</ArticleId><ArticleId IdType="pmc">PMC3161750</ArticleId><ArticleId IdType="pubmed">21887302</ArticleId></ArticleIdList></Reference><Reference><Citation>Marr AK, Jenssen H, Moniri MR, Hancock REW, Pant&#xe9; N. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie. 2009;91:160&#x2013;164. doi: 10.1016/j.biochi.2008.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2008.05.016</ArticleId><ArticleId IdType="pubmed">18573311</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepanto MS, et al. Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: an interventional study. Front. Immunol. 2018;9:2123. doi: 10.3389/fimmu.2018.02123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02123</ArticleId><ArticleId IdType="pmc">PMC6160582</ArticleId><ArticleId IdType="pubmed">30298070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaccorsi di Patti MC, et al. The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin. Biometals. 2018;31:399&#x2013;414. doi: 10.1007/s10534-018-0087-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-018-0087-5</ArticleId><ArticleId IdType="pubmed">29453656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimecki M, Actor JK, Kruzel ML. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm. Int. Immunopharmacol. 2021;95:107571. doi: 10.1016/j.intimp.2021.107571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107571</ArticleId><ArticleId IdType="pmc">PMC7953442</ArticleId><ArticleId IdType="pubmed">33765614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwirzitz A, et al. Lactoferrin is a natural inhibitor of plasminogen activation. J. Biol. Chem. 2018;293:8600&#x2013;8613. doi: 10.1074/jbc.RA118.003145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003145</ArticleId><ArticleId IdType="pmc">PMC5986228</ArticleId><ArticleId IdType="pubmed">29669808</ArticleId></ArticleIdList></Reference><Reference><Citation>Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern. Emerg. Med. 2020;15:1375&#x2013;1387. doi: 10.1007/s11739-020-02432-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02432-x</ArticleId><ArticleId IdType="pmc">PMC7352087</ArticleId><ArticleId IdType="pubmed">32653981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharova ET, Kostevich VA, Sokolov AV, Vasilyev VB. Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha. Biometals. 2012;25:1247&#x2013;1259. doi: 10.1007/s10534-012-9586-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-012-9586-y</ArticleId><ArticleId IdType="pubmed">23001680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharova ET, et al. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals. 2018;31:425&#x2013;443. doi: 10.1007/s10534-018-0111-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-018-0111-9</ArticleId><ArticleId IdType="pubmed">29748743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibuki M, et al. Lactoferrin has a therapeutic effect via HIF inhibition in a murine model of choroidal neovascularization. Front. Pharm. 2020;11:174. doi: 10.3389/fphar.2020.00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00174</ArticleId><ArticleId IdType="pmc">PMC7059857</ArticleId><ArticleId IdType="pubmed">32180725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryter SW, Choi AMK. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl. Res. 2016;167:7&#x2013;34. doi: 10.1016/j.trsl.2015.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2015.06.011</ArticleId><ArticleId IdType="pmc">PMC4857893</ArticleId><ArticleId IdType="pubmed">26166253</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan V, Wagener FADTG, Immenschuh S. The macrophage heme-heme oxygenase-1 system and its role in inflammation. Biochem. Pharm. 2018;153:159&#x2013;167. doi: 10.1016/j.bcp.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.02.010</ArticleId><ArticleId IdType="pubmed">29452096</ArticleId></ArticleIdList></Reference><Reference><Citation>Consoli V, Sorrenti V, Grosso S, Vanella L. Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules. 2021;11:589. doi: 10.3390/biom11040589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11040589</ArticleId><ArticleId IdType="pmc">PMC8072688</ArticleId><ArticleId IdType="pubmed">33923744</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu K-L, et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865&#x2013;8877. doi: 10.1096/fj.201802418R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802418R</ArticleId><ArticleId IdType="pmc">PMC6662968</ArticleId><ArticleId IdType="pubmed">31034780</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra N, De Souza C, Batra J, Raetz AG, Yu A-M. The HMOX1 pathway as a promising target for the treatment and prevention of SARS-CoV-2 of 2019 (COVID-19) IJMS. 2020;21:6412. doi: 10.3390/ijms21176412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176412</ArticleId><ArticleId IdType="pmc">PMC7503392</ArticleId><ArticleId IdType="pubmed">32899231</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, Piagnerelli M, Van Meerhaeghe A, Zouaoui Boudjeltia K. Heme oxygenase-1 (HO-1) cytoprotective pathway: a potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Med. Hypotheses. 2020;144:110242. doi: 10.1016/j.mehy.2020.110242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110242</ArticleId><ArticleId IdType="pmc">PMC7467863</ArticleId><ArticleId IdType="pubmed">33254548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra S, et al. Antiangiogenic effects and therapeutic targets of azadirachta indica leaf extract in endothelial cells. Evid. Based Complement Altern. Med. 2012;2012:303019. doi: 10.1155/2012/303019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/303019</ArticleId><ArticleId IdType="pmc">PMC3296311</ArticleId><ArticleId IdType="pubmed">22461839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-Y, Jang J-H, Li M-H, Surh Y-J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 2005;331:993&#x2013;1000. doi: 10.1016/j.bbrc.2005.03.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.03.237</ArticleId><ArticleId IdType="pubmed">15882976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong S-O, et al. Dimethoxycurcumin, a synthetic curcumin analogue, induces heme oxygenase-1 expression through Nrf2 activation in RAW264.7 macrophages. J. Clin. Biochem Nutr. 2009;44:79&#x2013;84. doi: 10.3164/jcbn.08-194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.08-194</ArticleId><ArticleId IdType="pmc">PMC2613503</ArticleId><ArticleId IdType="pubmed">19177192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao P, et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J. Hepatol. 2007;47:253&#x2013;261. doi: 10.1016/j.jhep.2007.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2007.02.008</ArticleId><ArticleId IdType="pubmed">17433488</ArticleId></ArticleIdList></Reference><Reference><Citation>Krantz SB. Erythropoietin. Blood. 1991;77:419&#x2013;434. doi: 10.1182/blood.V77.3.419.419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V77.3.419.419</ArticleId><ArticleId IdType="pubmed">1991159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020;92:915&#x2013;918. doi: 10.1002/jmv.25839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25839</ArticleId><ArticleId IdType="pmc">PMC7262240</ArticleId><ArticleId IdType="pubmed">32270515</ArticleId></ArticleIdList></Reference><Reference><Citation>Schobersberger W, Hoffmann G, Fandrey J. Nitric oxide donors suppress erythropoietin production in vitro. Pflug. Arch. 1996;432:980&#x2013;985. doi: 10.1007/s004240050225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004240050225</ArticleId><ArticleId IdType="pubmed">8781191</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruez-Soto A, et al. Low serum erythropoietin levels are associated with fatal COVID-19 cases at 4,150 meters above sea level. Respir. Physiol. Neurobiol. 2021;292:103709. doi: 10.1016/j.resp.2021.103709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103709</ArticleId><ArticleId IdType="pmc">PMC8169280</ArticleId><ArticleId IdType="pubmed">34087493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, et al. Covid-19 in critically Ill patients in the seattle region&#x2014;case series. N. Engl. J. Med. 2020;382:2012&#x2013;2022. doi: 10.1056/NEJMoa2004500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2004500</ArticleId><ArticleId IdType="pmc">PMC7143164</ArticleId><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaimanzadeh I. Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19) Cureus. 2020;12:e7343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7096066</ArticleId><ArticleId IdType="pubmed">32226695</ArticleId></ArticleIdList></Reference><Reference><Citation>Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can. J. Neurol. Sci. 2021;48:66&#x2013;76. doi: 10.1017/cjn.2020.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.146</ArticleId><ArticleId IdType="pmc">PMC7492583</ArticleId><ArticleId IdType="pubmed">32665054</ArticleId></ArticleIdList></Reference><Reference><Citation>Caravagna C, Soliz J. PI3K and MEK1/2 molecular pathways are involved in the erythropoietin-mediated regulation of the central respiratory command. Respir. Physiol. Neurobiol. 2015;206:36&#x2013;40. doi: 10.1016/j.resp.2014.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2014.11.012</ArticleId><ArticleId IdType="pubmed">25462838</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng T, Du S-Y, Son M, Diamond B. HIF-1&#x3b1; is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. Proc. Natl Acad. Sci. USA. 2021;118:e2106017118. doi: 10.1073/pnas.2106017118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2106017118</ArticleId><ArticleId IdType="pmc">PMC8256008</ArticleId><ArticleId IdType="pubmed">34108245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao F, et al. Suppression of NLRP3 inflammasome by erythropoietin via the EPOR/JAK2/STAT3 pathway contributes to attenuation of acute lung injury in mice. Front Pharm. 2020;11:306. doi: 10.3389/fphar.2020.00306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00306</ArticleId><ArticleId IdType="pmc">PMC7096553</ArticleId><ArticleId IdType="pubmed">32265704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich H, et al. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol. Med. 2020;26:58. doi: 10.1186/s10020-020-00186-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00186-y</ArticleId><ArticleId IdType="pmc">PMC7297268</ArticleId><ArticleId IdType="pubmed">32546125</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliz J, et al. Coping with hypoxemia: could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir. Physiol. Neurobiol. 2020;279:103476. doi: 10.1016/j.resp.2020.103476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103476</ArticleId><ArticleId IdType="pmc">PMC7275159</ArticleId><ArticleId IdType="pubmed">32522574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas G, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl Acad. Sci. USA. 2001;98:8780&#x2013;8785. doi: 10.1073/pnas.151179498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.151179498</ArticleId><ArticleId IdType="pmc">PMC37512</ArticleId><ArticleId IdType="pubmed">11447267</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher R, Karim Z. Iron metabolism: state of the art. Transfus. Clin. Biol. 2017;24:115&#x2013;119. doi: 10.1016/j.tracli.2017.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tracli.2017.06.015</ArticleId><ArticleId IdType="pubmed">28694024</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaneeswari M S, Ganesh M, Karthikeyan T, Devi AJM, Mythili SV. Hepcidin-minireview. J. Clin. Diagn. Res. 2013;7:1767&#x2013;1771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782966</ArticleId><ArticleId IdType="pubmed">24086909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravasi G, et al. Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS ONE. 2012;7:e36425. doi: 10.1371/journal.pone.0036425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036425</ArticleId><ArticleId IdType="pmc">PMC3346721</ArticleId><ArticleId IdType="pubmed">22586470</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J. Hepatol. 2011;54:173&#x2013;181. doi: 10.1016/j.jhep.2010.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2010.08.004</ArticleId><ArticleId IdType="pubmed">20932599</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, et al. Homocysteine upregulates hepcidin expression through BMP6/SMAD signaling pathway in hepatocytes. Biochem. Biophys. Res. Commun. 2016;471:303&#x2013;308. doi: 10.1016/j.bbrc.2016.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.02.001</ArticleId><ArticleId IdType="pubmed">26855134</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, et al. Calcitonin increases hepatic hepcidin expression through the BMP6 of kidney in mice. J. Trace Elem. Med. Biol. 2021;68:126796. doi: 10.1016/j.jtemb.2021.126796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2021.126796</ArticleId><ArticleId IdType="pubmed">34098241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen AW, et al. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology. 2013;58:1315&#x2013;1325. doi: 10.1002/hep.26490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26490</ArticleId><ArticleId IdType="pmc">PMC3770762</ArticleId><ArticleId IdType="pubmed">23703590</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada K, et al. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis. J. Gastroenterol. 2012;47:924&#x2013;935. doi: 10.1007/s00535-012-0552-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-012-0552-9</ArticleId><ArticleId IdType="pubmed">22367278</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed. Pharmacother. 2021;136:111228. doi: 10.1016/j.biopha.2021.111228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111228</ArticleId><ArticleId IdType="pmc">PMC7836924</ArticleId><ArticleId IdType="pubmed">33454595</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchette NL, Manz DH, Torti FM, Torti SV. Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Rev. Hematol. 2016;9:169&#x2013;186. doi: 10.1586/17474086.2016.1124757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17474086.2016.1124757</ArticleId><ArticleId IdType="pmc">PMC4849272</ArticleId><ArticleId IdType="pubmed">26669208</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchini F, Vallisa D, Maniscalco P, Capelli P. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients. Acta Biomed. 2020;91:e2020013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716981</ArticleId><ArticleId IdType="pubmed">32921750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060&#x2013;1072. doi: 10.1016/j.cell.2012.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs W, et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature. ESC Heart Fail. 2020;7:3772&#x2013;3781. doi: 10.1002/ehf2.12958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12958</ArticleId><ArticleId IdType="pmc">PMC7607145</ArticleId><ArticleId IdType="pubmed">32959998</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, et al. The emerging role of ferroptosis in inflammation. Biomed. Pharmacother. 2020;127:110108. doi: 10.1016/j.biopha.2020.110108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110108</ArticleId><ArticleId IdType="pubmed">32234642</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem. Biol. 2020;27:365&#x2013;375. doi: 10.1016/j.chembiol.2020.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7204503</ArticleId><ArticleId IdType="pubmed">32294465</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y-B, et al. Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis. Respir. Res. 2020;21:232. doi: 10.1186/s12931-020-01500-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01500-2</ArticleId><ArticleId IdType="pmc">PMC7488337</ArticleId><ArticleId IdType="pubmed">32907551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakol S, Seifalian AM. Vitamin E at a high dose as an anti-ferroptosis drug and not just a supplement for COVID-19 treatment. Biotechnol. Appl. Biochem. 2022;69:1058&#x2013;1060. doi: 10.1002/bab.2176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bab.2176</ArticleId><ArticleId IdType="pmc">PMC8239546</ArticleId><ArticleId IdType="pubmed">33938041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergin P, et al. The effects of vitamin E supplementation on malondialdehyde as a biomarker of oxidative stress in haemodialysis patients: a systematic review and meta-analysis. BMC Nephrol. 2021;22:126. doi: 10.1186/s12882-021-02328-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-021-02328-8</ArticleId><ArticleId IdType="pmc">PMC8034191</ArticleId><ArticleId IdType="pubmed">33832458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, et al. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo. Biochem. Biophys. Res. Commun. 2020;533:1442&#x2013;1448. doi: 10.1016/j.bbrc.2020.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.10.019</ArticleId><ArticleId IdType="pubmed">33109343</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto G, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28:101328. doi: 10.1016/j.redox.2019.101328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101328</ArticleId><ArticleId IdType="pmc">PMC6812032</ArticleId><ArticleId IdType="pubmed">31574461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, et al. Endothelial immunity trained by coronavirus infections, DAMP stimulations and regulated by anti-oxidant NRF2 may contribute to inflammations, myelopoiesis, COVID-19 cytokine storms and thromboembolism. Front. Immunol. 2021;12:653110. doi: 10.3389/fimmu.2021.653110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.653110</ArticleId><ArticleId IdType="pmc">PMC8269631</ArticleId><ArticleId IdType="pubmed">34248940</ArticleId></ArticleIdList></Reference><Reference><Citation>Han F, Li S, Yang Y, Bai Z. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered. 2021;12:5279&#x2013;5288. doi: 10.1080/21655979.2021.1964158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1964158</ArticleId><ArticleId IdType="pmc">PMC8806540</ArticleId><ArticleId IdType="pubmed">34402724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, et al. Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis. Oxid. Med. Cell Longev. 2020;2020:9067610. doi: 10.1155/2020/9067610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9067610</ArticleId><ArticleId IdType="pmc">PMC7732386</ArticleId><ArticleId IdType="pubmed">33343809</ArticleId></ArticleIdList></Reference><Reference><Citation>NaveenKumar SK, Hemshekhar M, Kemparaju K, Girish KS. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: protection by melatonin. Biochim. Biophys. Acta Mol. Basis Dis. 2019;1865:2303&#x2013;2316. doi: 10.1016/j.bbadis.2019.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.05.009</ArticleId><ArticleId IdType="pubmed">31102787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C-C, Wang P-H. Intravenous glycyrrhizin improved serum transaminases rapidly in a chronic hepatitis B patient with acute exacerbation. J. Formos. Med. Assoc. 2015;114:188&#x2013;189. doi: 10.1016/j.jfma.2012.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.08.012</ArticleId><ArticleId IdType="pubmed">25678183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen Q, Shi C, Jiao F, Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol. Med. Rep. 2019;20:4081&#x2013;4090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6797988</ArticleId><ArticleId IdType="pubmed">31545489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J. Adv. Res. 2021;28:231&#x2013;243. doi: 10.1016/j.jare.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7753233</ArticleId><ArticleId IdType="pubmed">33364059</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, et al. Ferroptosis-inhibitory difference between chebulagic acid and chebulinic acid indicates beneficial role of HHDP. Molecules. 2021;26:4300. doi: 10.3390/molecules26144300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26144300</ArticleId><ArticleId IdType="pmc">PMC8303713</ArticleId><ArticleId IdType="pubmed">34299576</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Hue M, et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 2019;33:8961&#x2013;8975. doi: 10.1096/fj.201900077R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900077R</ArticleId><ArticleId IdType="pubmed">31034781</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, et al. Comparison of ferroptosis-inhibitory mechanisms between ferrostatin-1 and dietary stilbenes (piceatannol and astringin) Molecules. 2021;26:1092. doi: 10.3390/molecules26041092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26041092</ArticleId><ArticleId IdType="pmc">PMC7922211</ArticleId><ArticleId IdType="pubmed">33669598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cant&#xf3; C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22:31&#x2013;53. doi: 10.1016/j.cmet.2015.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.05.023</ArticleId><ArticleId IdType="pmc">PMC4487780</ArticleId><ArticleId IdType="pubmed">26118927</ArticleId></ArticleIdList></Reference><Reference><Citation>Houtkooper RH, Cant&#xf3; C, Wanders RJ, Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 2010;31:194&#x2013;223. doi: 10.1210/er.2009-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2009-0026</ArticleId><ArticleId IdType="pmc">PMC2852209</ArticleId><ArticleId IdType="pubmed">20007326</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, et al. NAD+ metabolism-based immunoregulation and therapeutic potential. Cell Biosci. 2023;13:81. doi: 10.1186/s13578-023-01031-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-023-01031-5</ArticleId><ArticleId IdType="pmc">PMC10171153</ArticleId><ArticleId IdType="pubmed">37165408</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf8;mland &#xd8;, Diab J, Ferrario E, Sverkeli LJ, Ziegler M. The balance between NAD+ biosynthesis and consumption in ageing. Mech. Ageing Dev. 2021;199:111569. doi: 10.1016/j.mad.2021.111569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2021.111569</ArticleId><ArticleId IdType="pubmed">34509469</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous C, et al. Nicotinamide adenine dinucleotide: biosynthesis, consumption and therapeutic role in cardiac diseases. Acta Physiol. (Oxf.) 2021;231:e13551. doi: 10.1111/apha.13551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13551</ArticleId><ArticleId IdType="pubmed">32853469</ArticleId></ArticleIdList></Reference><Reference><Citation>Izadpanah A, et al. SARS-CoV-2 infection dysregulates NAD metabolism. Front. Immunol. 2023;14:1158455. doi: 10.3389/fimmu.2023.1158455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1158455</ArticleId><ArticleId IdType="pmc">PMC10344451</ArticleId><ArticleId IdType="pubmed">37457744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, et al. Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models. Cell Discov. 2022;8:38. doi: 10.1038/s41421-022-00409-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00409-y</ArticleId><ArticleId IdType="pmc">PMC9053567</ArticleId><ArticleId IdType="pubmed">35487885</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. NAD supplement alleviates intestinal barrier injury induced by ethanol via protecting epithelial mitochondrial function. Nutrients. 2022;15:174. doi: 10.3390/nu15010174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15010174</ArticleId><ArticleId IdType="pmc">PMC9823589</ArticleId><ArticleId IdType="pubmed">36615829</ArticleId></ArticleIdList></Reference><Reference><Citation>de Picciotto NE, et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell. 2016;15:522&#x2013;530. doi: 10.1111/acel.12461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12461</ArticleId><ArticleId IdType="pmc">PMC4854911</ArticleId><ArticleId IdType="pubmed">26970090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino J, Baur JA, Imai S-I. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27:513&#x2013;528. doi: 10.1016/j.cmet.2017.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.11.002</ArticleId><ArticleId IdType="pmc">PMC5842119</ArticleId><ArticleId IdType="pubmed">29249689</ArticleId></ArticleIdList></Reference><Reference><Citation>Daussin FN, et al. Dietary cocoa flavanols enhance mitochondrial function in skeletal muscle and modify whole-body metabolism in healthy mice. Nutrients. 2021;13:3466. doi: 10.3390/nu13103466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13103466</ArticleId><ArticleId IdType="pmc">PMC8538722</ArticleId><ArticleId IdType="pubmed">34684467</ArticleId></ArticleIdList></Reference><Reference><Citation>Omran HM, Almaliki MS. Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: a hypothesis. J. Infect. Public Health. 2020;13:1196&#x2013;1201. doi: 10.1016/j.jiph.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.06.004</ArticleId><ArticleId IdType="pmc">PMC7275989</ArticleId><ArticleId IdType="pubmed">32534944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansar H, Mazloom Z, Kazemi F, Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med. J. 2011;32:584&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">21666939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J-L, et al. Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma. Oncotarget. 2015;6:24032&#x2013;24046. doi: 10.18632/oncotarget.4429.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4429</ArticleId><ArticleId IdType="pmc">PMC4695168</ArticleId><ArticleId IdType="pubmed">26125228</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta. 2009;1790:1149&#x2013;1160. doi: 10.1016/j.bbagen.2009.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2009.07.026</ArticleId><ArticleId IdType="pmc">PMC2756298</ArticleId><ArticleId IdType="pubmed">19664690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J. Med. Virol. 2020;92:479&#x2013;490. doi: 10.1002/jmv.25707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25707</ArticleId><ArticleId IdType="pmc">PMC7166986</ArticleId><ArticleId IdType="pubmed">32052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cure E, Cumhur Cure M. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection. Med Hypotheses. 2020;143:110185. doi: 10.1016/j.mehy.2020.110185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110185</ArticleId><ArticleId IdType="pmc">PMC7427590</ArticleId><ArticleId IdType="pubmed">33017914</ArticleId></ArticleIdList></Reference><Reference><Citation>Uberti F, Ruga S, Farghali M, Galla R, Molinari C. A Combination of &#x3b1;-lipoic acid (ALA) and palmitoylethanolamide (PEA) blocks endotoxin-induced oxidative stress and cytokine storm: a possible intervention for COVID-19. J. Diet. Suppl. 2023;20:133&#x2013;155. doi: 10.1080/19390211.2021.1966152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2021.1966152</ArticleId><ArticleId IdType="pubmed">34405764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong M, et al. A randomized, single-blind, group sequential, active-controlled study to evaluate the clinical efficacy and safety of &#x3b1;-lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19) Front. Med. (Lausanne) 2021;8:566609. doi: 10.3389/fmed.2021.566609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.566609</ArticleId><ArticleId IdType="pmc">PMC8854372</ArticleId><ArticleId IdType="pubmed">35186959</ArticleId></ArticleIdList></Reference><Reference><Citation>Crane FL. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 2001;20:591&#x2013;598. doi: 10.1080/07315724.2001.10719063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2001.10719063</ArticleId><ArticleId IdType="pubmed">11771674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Camacho JD, Bernier M, L&#xf3;pez-Lluch G, Navas P. Coenzyme Q10 supplementation in aging and disease. Front. Physiol. 2018;9:44. doi: 10.3389/fphys.2018.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5807419</ArticleId><ArticleId IdType="pubmed">29459830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakhrolmobasheri M, et al. Coenzyme Q10 and its therapeutic potencies against COVID-19 and other similar infections: a molecular review. Adv. Pharm. Bull. 2023;13:233&#x2013;243. doi: 10.34172/apb.2023.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/apb.2023.026</ArticleId><ArticleId IdType="pmc">PMC10278218</ArticleId><ArticleId IdType="pubmed">37342382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, et al. Coenzyme Q10 attenuates human platelet aggregation induced by SARS-CoV-2 spike protein via reducing oxidative stress in vitro. Int J. Mol. Sci. 2022;23:12345. doi: 10.3390/ijms232012345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012345</ArticleId><ArticleId IdType="pmc">PMC9604356</ArticleId><ArticleId IdType="pubmed">36293203</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos, V. M. A potential role of coenzyme Q10 deficiency in severe SARS-cov2 infection. OBM Integrative and Complementary Medicine5, (2020).</Citation></Reference><Reference><Citation>Pagano G, et al. Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia. Inflamm. Res. 2021;70:159&#x2013;170. doi: 10.1007/s00011-020-01423-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01423-0</ArticleId><ArticleId IdType="pmc">PMC7750159</ArticleId><ArticleId IdType="pubmed">33346851</ArticleId></ArticleIdList></Reference><Reference><Citation>Turton N, Heaton RA, Hargreaves IP. COVID-19 and the assessment of coenzyme Q10. Methods Mol. Biol. 2022;2511:355&#x2013;365. doi: 10.1007/978-1-0716-2395-4_27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-2395-4_27</ArticleId><ArticleId IdType="pubmed">35838974</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestili P, et al. Creatine as an antioxidant. Amino Acids. 2011;40:1385&#x2013;1396. doi: 10.1007/s00726-011-0875-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-0875-5</ArticleId><ArticleId IdType="pubmed">21404063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic SM. Diagnostic and pharmacological potency of creatine in post-viral fatigue syndrome. Nutrients. 2021;13:503. doi: 10.3390/nu13020503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020503</ArticleId><ArticleId IdType="pmc">PMC7913646</ArticleId><ArticleId IdType="pubmed">33557013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic SM, et al. Supplementation with guanidinoacetic acid in women with chronic fatigue syndrome. Nutrients. 2016;8:72. doi: 10.3390/nu8020072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8020072</ArticleId><ArticleId IdType="pmc">PMC4772036</ArticleId><ArticleId IdType="pubmed">26840330</ArticleId></ArticleIdList></Reference><Reference><Citation>Riesberg LA, Weed SA, McDonald TL, Eckerson JM, Drescher KM. Beyond muscles: the untapped potential of creatine. Int. Immunopharmacol. 2016;37:31&#x2013;42. doi: 10.1016/j.intimp.2015.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2015.12.034</ArticleId><ArticleId IdType="pmc">PMC4915971</ArticleId><ArticleId IdType="pubmed">26778152</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall RP, Droste J-N, Giessing J, Kreider RB. Role of creatine supplementation in conditions involving mitochondrial dysfunction: a narrative review. Nutrients. 2022;14:529. doi: 10.3390/nu14030529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14030529</ArticleId><ArticleId IdType="pmc">PMC8838971</ArticleId><ArticleId IdType="pubmed">35276888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii K, Hosomi K, Sawane K, Kunisawa J. Metabolism of dietary and microbial vitamin b family in the regulation of host immunity. Front. Nutr. 2019;6:48. doi: 10.3389/fnut.2019.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2019.00048</ArticleId><ArticleId IdType="pmc">PMC6478888</ArticleId><ArticleId IdType="pubmed">31058161</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista KS, et al. The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the muscle-gut-brain axis and implications for SARS-CoV-2 infection. Nutr. Rev. 2022;80:561&#x2013;578. doi: 10.1093/nutrit/nuab092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuab092</ArticleId><ArticleId IdType="pmc">PMC8689946</ArticleId><ArticleId IdType="pubmed">34791425</ArticleId></ArticleIdList></Reference><Reference><Citation>Degnan PH, Taga ME, Goodman AL. Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 2014;20:769&#x2013;778. doi: 10.1016/j.cmet.2014.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.10.002</ArticleId><ArticleId IdType="pmc">PMC4260394</ArticleId><ArticleId IdType="pubmed">25440056</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolffenbuttel BHR, Wouters HJCM, Heiner-Fokkema MR, van der Klauw MM. The many faces of cobalamin (Vitamin B12) deficiency. Mayo Clin. Proc. Innov. Qual. Outcomes. 2019;3:200&#x2013;214. doi: 10.1016/j.mayocpiqo.2019.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2019.03.002</ArticleId><ArticleId IdType="pmc">PMC6543499</ArticleId><ArticleId IdType="pubmed">31193945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandeel M, Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci. 2020;251:117627. doi: 10.1016/j.lfs.2020.117627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117627</ArticleId><ArticleId IdType="pmc">PMC7194560</ArticleId><ArticleId IdType="pubmed">32251634</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 2020;20:515&#x2013;516. doi: 10.1038/s41577-020-0407-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0407-1</ArticleId><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed SA, Alahmadi YM, Abdou YA. The impact of serum levels of reactive oxygen and nitrogen species on the disease severity of COVID-19. Int J. Mol. Sci. 2023;24:8973. doi: 10.3390/ijms24108973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108973</ArticleId><ArticleId IdType="pmc">PMC10219364</ArticleId><ArticleId IdType="pubmed">37240319</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Branicky R, No&#xeb; A, Hekimi S. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J. Cell Biol. 2018;217:1915&#x2013;1928. doi: 10.1083/jcb.201708007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201708007</ArticleId><ArticleId IdType="pmc">PMC5987716</ArticleId><ArticleId IdType="pubmed">29669742</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos G, Messens J. Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radic. Biol. Med. 2011;51:314&#x2013;326. doi: 10.1016/j.freeradbiomed.2011.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.04.031</ArticleId><ArticleId IdType="pubmed">21605662</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat. Protoc. 2010;5:51&#x2013;66. doi: 10.1038/nprot.2009.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.197</ArticleId><ArticleId IdType="pmc">PMC2830880</ArticleId><ArticleId IdType="pubmed">20057381</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu, A. S. REDOX LIFE. 757 (Bio-Rep Network Media, 2013).</Citation></Reference><Reference><Citation>Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613&#x2013;619. doi: 10.1016/j.redox.2016.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.12.035</ArticleId><ArticleId IdType="pmc">PMC5256672</ArticleId><ArticleId IdType="pubmed">28110218</ArticleId></ArticleIdList></Reference><Reference><Citation>Golabi S, et al. Oxidative stress and inflammatory status in COVID-19 outpatients: a health center-based analytical cross-sectional study. Antioxid. (Basel) 2022;11:606. doi: 10.3390/antiox11040606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11040606</ArticleId><ArticleId IdType="pmc">PMC9024445</ArticleId><ArticleId IdType="pubmed">35453291</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti LF, et al. Decreased plasma H2O2 levels are associated with the pathogenesis leading to COVID-19 worsening and mortality. Free Radic. Res. 2022;56:740&#x2013;748. doi: 10.1080/10715762.2023.2174021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2023.2174021</ArticleId><ArticleId IdType="pubmed">36708322</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghoubi N, et al. Total antioxidant capacity as a marker of severity of COVID-19 infection: possible prognostic and therapeutic clinical application. J. Med. Virol. 2022;94:1558&#x2013;1565. doi: 10.1002/jmv.27500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27500</ArticleId><ArticleId IdType="pmc">PMC9015601</ArticleId><ArticleId IdType="pubmed">34862613</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol. Psychiatry. 2023;28:564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui K, Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm. Res. 2006;55:359&#x2013;363. doi: 10.1007/s00011-006-5195-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-006-5195-y</ArticleId><ArticleId IdType="pubmed">17122956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa AC, Corsi D, Cavi N, Bruni N, Dosio F. Superoxide dismutase administration: a review of proposed human uses. Molecules. 2021;26:1844. doi: 10.3390/molecules26071844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26071844</ArticleId><ArticleId IdType="pmc">PMC8037464</ArticleId><ArticleId IdType="pubmed">33805942</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol. Scand. Suppl. 1980;492:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">6939305</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi R, Hoshino J, Ochiai A, Morizawa Y, Mizushima Y. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J. Pharm. Exp. Ther. 1994;271:1672&#x2013;1677.</Citation><ArticleIdList><ArticleId IdType="pubmed">7996483</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, et al. Pharmacokinetics and safety of PC-SOD, a lecithinized recombinant superoxide dismutase, in healthy Chinese subjects: A phase 1, randomized, placebo-controlled, dose-escalation study. Int J. Clin. Pharm. Ther. 2019;57:596&#x2013;602. doi: 10.5414/CP203550.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CP203550</ArticleId><ArticleId IdType="pubmed">31599225</ArticleId></ArticleIdList></Reference><Reference><Citation>Farella I, Panza R, Capozza M, Laforgia N. Lecithinized superoxide dismutase in the past and in the present: any role in the actual pandemia of COVID-19? Biomed. Pharmacother. 2021;141:111922. doi: 10.1016/j.biopha.2021.111922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111922</ArticleId><ArticleId IdType="pmc">PMC8277551</ArticleId><ArticleId IdType="pubmed">34323703</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal MM, Basak A. Human catalase: looking for complete identity. Protein Cell. 2010;1:888&#x2013;897. doi: 10.1007/s13238-010-0113-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0113-z</ArticleId><ArticleId IdType="pmc">PMC4875117</ArticleId><ArticleId IdType="pubmed">21204015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, Cederbaum AI. Mitochondrial catalase and oxidative injury. Biol. Signals Recept. 2001;10:189&#x2013;199. doi: 10.1159/000046887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000046887</ArticleId><ArticleId IdType="pubmed">11351128</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebicka L, Krych-Madej J. The role of catalases in the prevention/promotion of oxidative stress. J. Inorg. Biochem. 2019;197:110699. doi: 10.1016/j.jinorgbio.2019.110699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2019.110699</ArticleId><ArticleId IdType="pubmed">31055214</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, et al. Evidence for CAT gene being functionally involved in the susceptibility of COVID-19. FASEB J. 2021;35:e21384. doi: 10.1096/fj.202100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100008</ArticleId><ArticleId IdType="pmc">PMC8250337</ArticleId><ArticleId IdType="pubmed">33710662</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin M, et al. An antioxidant enzyme therapeutic for COVID-19. Adv. Mater. 2020;32:e2004901. doi: 10.1002/adma.202004901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202004901</ArticleId><ArticleId IdType="pubmed">32924219</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi C, Chen Y, Huang J-H, Jin Q-Z, Wang X-G. Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine. J. Sci. Food Agric. 2012;92:787&#x2013;793. doi: 10.1002/jsfa.4646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jsfa.4646</ArticleId><ArticleId IdType="pubmed">22101976</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. Dietary catalase supplementation alleviates deoxynivalenol-induced oxidative stress and gut microbiota dysbiosis in broiler chickens. Toxins (Basel) 2022;14:830. doi: 10.3390/toxins14120830.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins14120830</ArticleId><ArticleId IdType="pmc">PMC9784562</ArticleId><ArticleId IdType="pubmed">36548727</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBlanc JG, et al. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn&#x2019;s disease in mice. J. Biotechnol. 2011;151:287&#x2013;293. doi: 10.1016/j.jbiotec.2010.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2010.11.008</ArticleId><ArticleId IdType="pubmed">21167883</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Carmen S, et al. Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities. Appl. Environ. Microbiol. 2014;80:869&#x2013;877. doi: 10.1128/AEM.03296-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.03296-13</ArticleId><ArticleId IdType="pmc">PMC3911219</ArticleId><ArticleId IdType="pubmed">24242245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat. Commun. 2022;13:3432. doi: 10.1038/s41467-022-31171-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31171-0</ArticleId><ArticleId IdType="pmc">PMC9198027</ArticleId><ArticleId IdType="pubmed">35701435</ArticleId></ArticleIdList></Reference><Reference><Citation>Oestreicher J, Morgan B. Glutathione: subcellular distribution and membrane transport 1. Biochem. Cell Biol. 2019;97:270&#x2013;289. doi: 10.1139/bcb-2018-0189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2018-0189</ArticleId><ArticleId IdType="pubmed">30427707</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DP, et al. Redox state of glutathione in human plasma. Free Radic. Biol. Med. 2000;28:625&#x2013;635. doi: 10.1016/S0891-5849(99)00275-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(99)00275-0</ArticleId><ArticleId IdType="pubmed">10719244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed; M, et al. Mitochondrial glutathione: recent insights and role in disease. Antioxidants (Basel) 2020;9:909. doi: 10.3390/antiox9100909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100909</ArticleId><ArticleId IdType="pmc">PMC7598719</ArticleId><ArticleId IdType="pubmed">32987701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992;257:1496&#x2013;1502. doi: 10.1126/science.1523409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1523409</ArticleId><ArticleId IdType="pubmed">1523409</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001;30:1191&#x2013;1212. doi: 10.1016/S0891-5849(01)00480-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(01)00480-4</ArticleId><ArticleId IdType="pubmed">11368918</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu. Rev. Pharm. Toxicol. 2005;45:51&#x2013;88. doi: 10.1146/annurev.pharmtox.45.120403.095857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pharmtox.45.120403.095857</ArticleId><ArticleId IdType="pubmed">15822171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillig CH, Berndt C, Holmgren A. Glutaredoxin systems. Biochim. Biophys. Acta. 2008;1780:1304&#x2013;1317. doi: 10.1016/j.bbagen.2008.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2008.06.003</ArticleId><ArticleId IdType="pubmed">18621099</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H, Reichert AS. Selectively addressing mitochondrial glutathione and thioredoxin redox systems. Cell Chem. Biol. 2019;26:316&#x2013;318. doi: 10.1016/j.chembiol.2019.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2019.02.017</ArticleId><ArticleId IdType="pubmed">30901559</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Asp. Med. 2009;30:1&#x2013;12. doi: 10.1016/j.mam.2008.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2008.08.006</ArticleId><ArticleId IdType="pmc">PMC2696075</ArticleId><ArticleId IdType="pubmed">18796312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed; M, et al. Mitochondrial glutathione: features, regulation and role in disease. Biochim. Biophys. Acta. 2013;1830:3317&#x2013;3328. doi: 10.1016/j.bbagen.2012.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.10.018</ArticleId><ArticleId IdType="pmc">PMC3578987</ArticleId><ArticleId IdType="pubmed">23123815</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 2011;208:417&#x2013;420. doi: 10.1084/jem.20110367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20110367</ArticleId><ArticleId IdType="pmc">PMC3058577</ArticleId><ArticleId IdType="pubmed">21357740</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr. Top. Microbiol Immunol. 2017;403:143&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">28204974</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonikov A. Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients. ACS Infect. Dis. 2020;6:1558&#x2013;1562. doi: 10.1021/acsinfecdis.0c00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00288</ArticleId><ArticleId IdType="pubmed">32463221</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodore M, et al. Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2. J. Biol. Chem. 2008;283:8984&#x2013;8994. doi: 10.1074/jbc.M709040200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M709040200</ArticleId><ArticleId IdType="pmc">PMC2276363</ArticleId><ArticleId IdType="pubmed">18238777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims AC, et al. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J. Virol. 2013;87:3885&#x2013;3902. doi: 10.1128/JVI.02520-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02520-12</ArticleId><ArticleId IdType="pmc">PMC3624188</ArticleId><ArticleId IdType="pubmed">23365422</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F, Vernone A, Pescarmona GP. The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19. Antioxidants (Basel) 2020;9:624. doi: 10.3390/antiox9070624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070624</ArticleId><ArticleId IdType="pmc">PMC7402141</ArticleId><ArticleId IdType="pubmed">32708578</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora-Mendoza R, et al. Dysregulation of mitochondrial function and biogenesis modulators in adipose tissue of obese children. Int J. Obes. (Lond.) 2018;42:618&#x2013;624. doi: 10.1038/ijo.2017.274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2017.274</ArticleId><ArticleId IdType="pubmed">29158541</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassman I, et al. The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review. Front Biosci. (Landmark Ed.) 2023;28:59. doi: 10.31083/j.fbl2803059.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2803059</ArticleId><ArticleId IdType="pmc">PMC10406467</ArticleId><ArticleId IdType="pubmed">37005767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic. Biol. Med. 2020;152:175&#x2013;185. doi: 10.1016/j.freeradbiomed.2020.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.02.027</ArticleId><ArticleId IdType="pubmed">32165281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130:1787. doi: 10.1002/lary.28692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28692</ArticleId><ArticleId IdType="pmc">PMC7228304</ArticleId><ArticleId IdType="pubmed">32237238</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiorino M, et al. Probing the presumed catalytic triad of selenium-containing peroxidases by mutational analysis of phospholipid hydroperoxide glutathione peroxidase (PHGPx) Biol. Chem. Hoppe Seyler. 1995;376:651&#x2013;660. doi: 10.1515/bchm3.1995.376.11.651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bchm3.1995.376.11.651</ArticleId><ArticleId IdType="pubmed">8962674</ArticleId></ArticleIdList></Reference><Reference><Citation>Guloyan V, et al. Glutathione supplementation as an adjunctive therapy in COVID-19. Antioxidants (Basel) 2020;9:914. doi: 10.3390/antiox9100914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100914</ArticleId><ArticleId IdType="pmc">PMC7601802</ArticleId><ArticleId IdType="pubmed">32992775</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardiolo G, Bramanti P, Mazzon E. Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules. 2018;23:3305. doi: 10.3390/molecules23123305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23123305</ArticleId><ArticleId IdType="pmc">PMC6320789</ArticleId><ArticleId IdType="pubmed">30551603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim H, et al. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clin. Immunol. 2020;219:108544. doi: 10.1016/j.clim.2020.108544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108544</ArticleId><ArticleId IdType="pmc">PMC7374140</ArticleId><ArticleId IdType="pubmed">32707089</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto ME, et al. N-Acetyl cysteine restores the diminished activity of the antioxidant enzymatic system caused by SARS-CoV-2 infection: preliminary findings. Pharm. (Basel) 2023;16:591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10146435</ArticleId><ArticleId IdType="pubmed">37111348</ArticleId></ArticleIdList></Reference><Reference><Citation>du Preez HN, Aldous C, Kruger HG, Johnson L. N-Acetylcysteine and other sulfur-donors as a preventative and adjunct therapy for COVID-19. Adv. Pharm. Pharm. Sci. 2022;2022:4555490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385285</ArticleId><ArticleId IdType="pubmed">35992575</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo JL, et al. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. Sci. Prog. 2022;105:368504221074574. doi: 10.1177/00368504221074574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00368504221074574</ArticleId><ArticleId IdType="pmc">PMC8795755</ArticleId><ArticleId IdType="pubmed">35084258</ArticleId></ArticleIdList></Reference><Reference><Citation>Avdeev SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG-M. N-acetylcysteine for the treatment of COVID-19 among hospitalized patients. J. Infect. 2022;84:94&#x2013;118. doi: 10.1016/j.jinf.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8271031</ArticleId><ArticleId IdType="pubmed">34252497</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, et al. Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study. ERJ Open Res. 2022;8:00542&#x2013;02021. doi: 10.1183/23120541.00542-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2021</ArticleId><ArticleId IdType="pmc">PMC8646003</ArticleId><ArticleId IdType="pubmed">35136824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya R, et al. The beneficial role of N-acetylcysteine as an adjunctive drug in treatment of COVID-19 patients in a tertiary care hospital in India: an observational study. Int J. Res. Med. Sci. 2020;8:3518. doi: 10.18203/2320-6012.ijrms20204010.</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2320-6012.ijrms20204010</ArticleId></ArticleIdList></Reference><Reference><Citation>De Flora S, Balansky R, La Maestra S. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB J. 2020;34:13185&#x2013;13193. doi: 10.1096/fj.202001807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001807</ArticleId><ArticleId IdType="pmc">PMC7436914</ArticleId><ArticleId IdType="pubmed">32780893</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, Puyo CA. N-Acetylcysteine to combat COVID-19: an evidence review. Ther. Clin. Risk Manag. 2020;16:1047&#x2013;1055. doi: 10.2147/TCRM.S273700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S273700</ArticleId><ArticleId IdType="pmc">PMC7649937</ArticleId><ArticleId IdType="pubmed">33177829</ArticleId></ArticleIdList></Reference><Reference><Citation>Micheletto C, Izquierdo JL, Avdeev SN, Rada Escobar RA, Pacheco Gallego MC. N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment. Eur. Rev. Med. Pharm. Sci. 2022;26:4872&#x2013;4880.</Citation><ArticleIdList><ArticleId IdType="pubmed">35856379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M, Horriatkhah E, Mohajery R. The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study. Inflammopharmacology. 2021;29:1769&#x2013;1776. doi: 10.1007/s10787-021-00881-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00881-0</ArticleId><ArticleId IdType="pmc">PMC8552429</ArticleId><ArticleId IdType="pubmed">34709541</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak BV, et al. COVID-19 and oxidative stress. Biochemistry (Mosc.) 2020;85:1543&#x2013;1553. doi: 10.1134/S0006297920120068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297920120068</ArticleId><ArticleId IdType="pmc">PMC7768996</ArticleId><ArticleId IdType="pubmed">33705292</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12:1562. doi: 10.3390/nu12061562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061562</ArticleId><ArticleId IdType="pmc">PMC7352291</ArticleId><ArticleId IdType="pubmed">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients. 2018;10:1564. doi: 10.3390/nu10111564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111564</ArticleId><ArticleId IdType="pmc">PMC6266414</ArticleId><ArticleId IdType="pubmed">30360490</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C-Y, et al. The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with age-related diseases. Molecules. 2020;25:5591. doi: 10.3390/molecules25235591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25235591</ArticleId><ArticleId IdType="pmc">PMC7729569</ArticleId><ArticleId IdType="pubmed">33261212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nooshkam M, Varidi M, Bashash M. The Maillard reaction products as food-born antioxidant and antibrowning agents in model and real food systems. Food Chem. 2019;275:644&#x2013;660. doi: 10.1016/j.foodchem.2018.09.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2018.09.083</ArticleId><ArticleId IdType="pubmed">30724245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, et al. Increase of rutin antioxidant activity by generating Maillard reaction products with lysine. Bioorg. Med. Chem. Lett. 2016;26:2680&#x2013;2684. doi: 10.1016/j.bmcl.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2016.04.008</ArticleId><ArticleId IdType="pubmed">27106712</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, et al. Enhancing the antioxidative effects of foods containing rutin and &#x3b1;-amino acids via the Maillard reaction: A model study focusing on rutin-lysine system. J. Food Biochem. 2020;44:e13086.</Citation><ArticleIdList><ArticleId IdType="pubmed">31646664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J. Mol. Sci. 2023;24:9352. doi: 10.3390/ijms24119352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119352</ArticleId><ArticleId IdType="pmc">PMC10253853</ArticleId><ArticleId IdType="pubmed">37298303</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#xed;as-P&#xe9;rez D, et al. Relationship of quercetin intake and oxidative stress in persistent COVID. Front. Nutr. 2023;10:1278039. doi: 10.3389/fnut.2023.1278039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1278039</ArticleId><ArticleId IdType="pmc">PMC10800910</ArticleId><ArticleId IdType="pubmed">38260057</ArticleId></ArticleIdList></Reference><Reference><Citation>Glinsky GV. Tripartite combination of candidate pandemic mitigation agents: vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomics-guided tracing of SARS-CoV-2 targets in human cells. Biomedicines. 2020;8:129. doi: 10.3390/biomedicines8050129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8050129</ArticleId><ArticleId IdType="pmc">PMC7277789</ArticleId><ArticleId IdType="pubmed">32455629</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19) Platelets. 2020;31:627&#x2013;632. doi: 10.1080/09537104.2020.1762852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1762852</ArticleId><ArticleId IdType="pubmed">32397915</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;chter K, et al. AGE-rich bread crust extract boosts oxidative stress interception via stimulation of the NRF2 pathway. Nutrients. 2021;13:3874. doi: 10.3390/nu13113874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113874</ArticleId><ArticleId IdType="pmc">PMC8622267</ArticleId><ArticleId IdType="pubmed">34836129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhs S, et al. Preconditioning with Maillard reaction products improves antioxidant defence leading to increased stress tolerance in cardiac cells. Exp. Gerontol. 2010;45:752&#x2013;762. doi: 10.1016/j.exger.2010.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2010.08.001</ArticleId><ArticleId IdType="pubmed">20705126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, et al. Simultaneous ultrasound and heat enhance functional properties of glycosylated lactoferrin. Molecules. 2020;25:5774. doi: 10.3390/molecules25235774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25235774</ArticleId><ArticleId IdType="pmc">PMC7730217</ArticleId><ArticleId IdType="pubmed">33297553</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CH, Choi JS, Yokozawa T. Increase in the hydroxyl radical-scavenging activity of Panax ginseng and ginsenosides by heat-processing. Drug Discov. Ther. 2018;12:114&#x2013;121. doi: 10.5582/ddt.2018.01010.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2018.01010</ArticleId><ArticleId IdType="pubmed">29998991</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh NS, et al. Chemical characteristics and enhanced hepatoprotective activities of Maillard reaction products derived from milk protein-sugar system. J. Dairy Sci. 2016;99:947&#x2013;958. doi: 10.3168/jds.2015-10009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2015-10009</ArticleId><ArticleId IdType="pubmed">26627852</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh NS, et al. Preventive effect of fermented Maillard reaction products from milk proteins in cardiovascular health. J. Dairy Sci. 2014;97:3300&#x2013;3313. doi: 10.3168/jds.2013-7728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2013-7728</ArticleId><ArticleId IdType="pubmed">24731635</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, et al. Potential effects of rapeseed peptide Maillard reaction products on aging-related disorder attenuation and gut microbiota modulation in d-galactose induced aging mice. Food Funct. 2019;10:4291&#x2013;4303. doi: 10.1039/C9FO00791A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9FO00791A</ArticleId><ArticleId IdType="pubmed">31265043</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr. Metab. (Lond.) 2010;7:30. doi: 10.1186/1743-7075-7-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-7-30</ArticleId><ArticleId IdType="pmc">PMC2861661</ArticleId><ArticleId IdType="pubmed">20398344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabito Colafella KM, Bov&#xe9;e DM, Danser AHJ. The renin-angiotensin-aldosterone system and its therapeutic targets. Exp. Eye Res. 2019;186:107680. doi: 10.1016/j.exer.2019.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2019.05.020</ArticleId><ArticleId IdType="pubmed">31129252</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel &#xc9;B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanca AJ, et al. l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-&#x3ba;B translocation to the nucleus. Food Chem. 2017;228:356&#x2013;366. doi: 10.1016/j.foodchem.2017.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2017.02.011</ArticleId><ArticleId IdType="pubmed">28317735</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z, et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur. Rev. Med Pharm. Sci. 2021;25:67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaziri-Harami R, Delkash P. Can l-carnitine reduce post-COVID-19 fatigue? Ann. Med. Surg. (Lond.) 2022;73:103145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667465</ArticleId><ArticleId IdType="pubmed">34925826</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui H, et al. L-Carnitine supplementation reduces the general fatigue of cancer patients during chemotherapy. Mol. Clin. Oncol. 2018;8:413&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5795559</ArticleId><ArticleId IdType="pubmed">29456846</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasiljevski ER, et al. L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: a Phase 2a clinical trial. Am. J. Med. Genet. A. 2021;185:2976&#x2013;2985. doi: 10.1002/ajmg.a.62392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.62392</ArticleId><ArticleId IdType="pmc">PMC9290089</ArticleId><ArticleId IdType="pubmed">34155781</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx W, et al. Efficacy and effectiveness of carnitine supplementation for cancer-related fatigue: a systematic literature review and meta-analysis. Nutrients. 2017;9:1224. doi: 10.3390/nu9111224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111224</ArticleId><ArticleId IdType="pmc">PMC5707696</ArticleId><ArticleId IdType="pubmed">29112178</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter SE, Evans AM. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J. Intern. Med. 2011;270:76&#x2013;84. doi: 10.1111/j.1365-2796.2010.02341.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2010.02341.x</ArticleId><ArticleId IdType="pubmed">21205027</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgens IPA, Santana NM, Lima SCVC, Fayh APT. Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. Br. J. Nutr. 2021;126:552&#x2013;560. doi: 10.1017/S0007114520004420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114520004420</ArticleId><ArticleId IdType="pmc">PMC7711335</ArticleId><ArticleId IdType="pubmed">33261670</ArticleId></ArticleIdList></Reference><Reference><Citation>Miedema JR, et al. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients. Front. Immunol. 2023;14:1204433. doi: 10.3389/fimmu.2023.1204433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1204433</ArticleId><ArticleId IdType="pmc">PMC10446834</ArticleId><ArticleId IdType="pubmed">37622126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayi BS, et al. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021;17:e1009153. doi: 10.1371/journal.ppat.1009153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009153</ArticleId><ArticleId IdType="pmc">PMC7781380</ArticleId><ArticleId IdType="pubmed">33395426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell. 2021;28:331&#x2013;342.e5. doi: 10.1016/j.stem.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7832490</ArticleId><ArticleId IdType="pubmed">33450186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty N, et al. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett. 2021;595:2854&#x2013;2871. doi: 10.1002/1873-3468.14227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14227</ArticleId><ArticleId IdType="pmc">PMC8652524</ArticleId><ArticleId IdType="pubmed">34757622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika E-F, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78:682&#x2013;683. doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D, et al. Post-acute COVID-19 neurological syndrome: a new medical challenge. J. Clin. Med. 2021;10:1947. doi: 10.3390/jcm10091947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10091947</ArticleId><ArticleId IdType="pmc">PMC8124354</ArticleId><ArticleId IdType="pubmed">34062770</ArticleId></ArticleIdList></Reference><Reference><Citation>Diem L, et al. Fatigue in post-COVID-19 syndrome: clinical phenomenology, comorbidities and association with initial course of COVID-19. J. Cent. Nerv. Syst. Dis. 2022;14:11795735221102727. doi: 10.1177/11795735221102727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11795735221102727</ArticleId><ArticleId IdType="pmc">PMC9130865</ArticleId><ArticleId IdType="pubmed">35633835</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunata M, Parlakpinar H, Acet HA. Melatonin: a review of its potential functions and effects on neurological diseases. Rev. Neurol. (Paris) 2020;176:148&#x2013;165. doi: 10.1016/j.neurol.2019.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.07.025</ArticleId><ArticleId IdType="pubmed">31718830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman MR. Temporal organization of pineal melatonin signaling in mammals. Mol. Cell Endocrinol. 2020;503:110687. doi: 10.1016/j.mce.2019.110687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2019.110687</ArticleId><ArticleId IdType="pubmed">31866317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip H-K, et al. Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J. Pineal Res. 2013;54:207&#x2013;221. doi: 10.1111/jpi.12020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12020</ArticleId><ArticleId IdType="pubmed">23110436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitimus DM, et al. Melatonin&#x2019;s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 2020;10:1211. doi: 10.3390/biom10091211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10091211</ArticleId><ArticleId IdType="pmc">PMC7563541</ArticleId><ArticleId IdType="pubmed">32825327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinali DP, Brown GM, Pandi-Perumal SR. Possible application of melatonin in long COVID. Biomolecules. 2022;12:1646. doi: 10.3390/biom12111646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12111646</ArticleId><ArticleId IdType="pmc">PMC9687267</ArticleId><ArticleId IdType="pubmed">36358996</ArticleId></ArticleIdList></Reference><Reference><Citation>Galano A, Tan D-X, Reiter RJ. Melatonin: a versatile protector against oxidative dna damage. Molecules. 2018;23:530. doi: 10.3390/molecules23030530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23030530</ArticleId><ArticleId IdType="pmc">PMC6017920</ArticleId><ArticleId IdType="pubmed">29495460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Jurado A, et al. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology. 2022;30:1569&#x2013;1596. doi: 10.1007/s10787-022-01011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01011-0</ArticleId><ArticleId IdType="pmc">PMC9167428</ArticleId><ArticleId IdType="pubmed">35665873</ArticleId></ArticleIdList></Reference><Reference><Citation>Habtemariam S, et al. Melatonin and respiratory diseases: a review. Curr. Top. Med. Chem. 2017;17:467&#x2013;488. doi: 10.2174/1568026616666160824120338.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666160824120338</ArticleId><ArticleId IdType="pubmed">27558675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardeland R. Melatonin and inflammation-story of a double-edged blade. J. Pineal Res. 2018;65:e12525. doi: 10.1111/jpi.12525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12525</ArticleId><ArticleId IdType="pubmed">30242884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Z, Ashrafizadeh M. Melatonin as a potential modulator of Nrf2. Fundam. Clin. Pharm. 2020;34:11&#x2013;19. doi: 10.1111/fcp.12498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fcp.12498</ArticleId><ArticleId IdType="pubmed">31283051</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter RJ, et al. Melatonin mitigates mitochondrial meltdown: interactions with SIRT3. Int J. Mol. Sci. 2018;19:2439. doi: 10.3390/ijms19082439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082439</ArticleId><ArticleId IdType="pmc">PMC6121285</ArticleId><ArticleId IdType="pubmed">30126181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D-X, Hardeland R. Targeting host defense system and rescuing compromised mitochondria to increase tolerance against pathogens by melatonin may impact outcome of deadly virus infection pertinent to COVID-19. Molecules. 2020;25:4410. doi: 10.3390/molecules25194410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25194410</ArticleId><ArticleId IdType="pmc">PMC7582936</ArticleId><ArticleId IdType="pubmed">32992875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichniak A, Kania A, Siemi&#x144;ski M, Cuba&#x142;a WJ. Melatonin as a potential adjuvant treatment for COVID-19 Beyond Sleep Disorders. Int J. Mol. Sci. 2021;22:8623. doi: 10.3390/ijms22168623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168623</ArticleId><ArticleId IdType="pmc">PMC8395320</ArticleId><ArticleId IdType="pubmed">34445329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X-C, Wu G-L, Cai Y-F, Zhang S-J. The safety and efficacy of melatonin in the treatment of COVID-19: a systematic review and meta-analysis. Med. (Baltim.) 2022;101:e30874. doi: 10.1097/MD.0000000000030874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000030874</ArticleId><ArticleId IdType="pmc">PMC9524532</ArticleId><ArticleId IdType="pubmed">36181086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi SA, et al. Melatonin effects on sleep quality and outcomes of COVID-19 patients: an open-label, randomized, controlled trial. J. Med Virol. 2022;94:263&#x2013;271. doi: 10.1002/jmv.27312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27312</ArticleId><ArticleId IdType="pmc">PMC8662261</ArticleId><ArticleId IdType="pubmed">34460132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bologna C, Madonna P, Pone E. Efficacy of prolonged-release melatonin 2 mg (PRM 2 mg) prescribed for insomnia in hospitalized patients for COVID-19: a retrospective observational study. J. Clin. Med. 2021;10:5857. doi: 10.3390/jcm10245857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245857</ArticleId><ArticleId IdType="pmc">PMC8705392</ArticleId><ArticleId IdType="pubmed">34945156</ArticleId></ArticleIdList></Reference><Reference><Citation>Comai S, Ochoa-Sanchez R, Gobbi G. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice. Behav. Brain Res. 2013;243:231&#x2013;238. doi: 10.1016/j.bbr.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2013.01.008</ArticleId><ArticleId IdType="pubmed">23333399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi: 10.1016/j.lfs.2020.117583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117583</ArticleId><ArticleId IdType="pmc">PMC7102583</ArticleId><ArticleId IdType="pubmed">32217117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram S, et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 2011;85:13363&#x2013;13372. doi: 10.1128/JVI.05300-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05300-11</ArticleId><ArticleId IdType="pmc">PMC3233180</ArticleId><ArticleId IdType="pubmed">21994442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatesuer B, et al. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog. 2013;9:e1003774. doi: 10.1371/journal.ppat.1003774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003774</ArticleId><ArticleId IdType="pmc">PMC3857797</ArticleId><ArticleId IdType="pubmed">24348248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuoka S, et al. Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. Am. J. Respir. Cell Mol. Biol. 1997;16:300&#x2013;308. doi: 10.1165/ajrcmb.16.3.9070615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.16.3.9070615</ArticleId><ArticleId IdType="pubmed">9070615</ArticleId></ArticleIdList></Reference><Reference><Citation>Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J. Tuberc. Lung Dis. 2008;12:361&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">18371259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersul AL, et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch. Bronconeumol. 2011;47:176&#x2013;183. doi: 10.1016/j.arbres.2010.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2010.12.003</ArticleId><ArticleId IdType="pubmed">21454005</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Jaspers I. Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. Am. J. Physiol. Lung Cell Mol. Physiol. 2015;308:L1189&#x2013;L1201. doi: 10.1152/ajplung.00028.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00028.2015</ArticleId><ArticleId IdType="pmc">PMC4587599</ArticleId><ArticleId IdType="pubmed">25888573</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzie IF. Evolution of antioxidant defence mechanisms. Eur. J. Nutr. 2000;39:53&#x2013;61. doi: 10.1007/s003940070030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s003940070030</ArticleId><ArticleId IdType="pubmed">10918985</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudice A, Arra C, Turco MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 2010;647:37&#x2013;74. doi: 10.1007/978-1-60761-738-9_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-738-9_3</ArticleId><ArticleId IdType="pubmed">20694660</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz MA, et al. Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells. PLoS ONE. 2014;9:e87204. doi: 10.1371/journal.pone.0087204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087204</ArticleId><ArticleId IdType="pmc">PMC3899380</ArticleId><ArticleId IdType="pubmed">24466341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic. Biol. Med. 2011;51:444&#x2013;453. doi: 10.1016/j.freeradbiomed.2011.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.04.027</ArticleId><ArticleId IdType="pmc">PMC3135631</ArticleId><ArticleId IdType="pubmed">21549835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y-J, Lee S-H. Sulforaphane induces antioxidative and antiproliferative responses by generating reactive oxygen species in human bronchial epithelial BEAS-2B cells. J. Korean Med. Sci. 2011;26:1474&#x2013;1482. doi: 10.3346/jkms.2011.26.11.1474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2011.26.11.1474</ArticleId><ArticleId IdType="pmc">PMC3207051</ArticleId><ArticleId IdType="pubmed">22065904</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanzaro M, et al. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target Ther. 2020;5:84. doi: 10.1038/s41392-020-0191-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0191-1</ArticleId><ArticleId IdType="pmc">PMC7255975</ArticleId><ArticleId IdType="pubmed">32467561</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdoway A. Nutritional management of patients during and after COVID-19 illness. Br. J. Community Nurs. 2020;25:S6&#x2013;S10. doi: 10.12968/bjcn.2020.25.Sup8.S6.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjcn.2020.25.Sup8.S6</ArticleId><ArticleId IdType="pubmed">32936703</ArticleId></ArticleIdList></Reference><Reference><Citation>Antwi J, Appiah B, Oluwakuse B, Abu BAZ. The nutrition-COVID-19 interplay: a review. Curr. Nutr. Rep. 2021;10:364&#x2013;374. doi: 10.1007/s13668-021-00380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-021-00380-2</ArticleId><ArticleId IdType="pmc">PMC8627159</ArticleId><ArticleId IdType="pubmed">34837637</ArticleId></ArticleIdList></Reference><Reference><Citation>Junaid K, et al. Effective immune functions of micronutrients against SARS-CoV-2. Nutrients. 2020;12:2992. doi: 10.3390/nu12102992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12102992</ArticleId><ArticleId IdType="pmc">PMC7599934</ArticleId><ArticleId IdType="pubmed">33003648</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe FL, et al. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr. 2011;14:340&#x2013;346. doi: 10.1017/S1368980010002454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980010002454</ArticleId><ArticleId IdType="pubmed">20854716</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Cancer, sunlight and vitamin D. J. Clin. Transl. Endocrinol. 2014;1:179&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685053</ArticleId><ArticleId IdType="pubmed">29159099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235. doi: 10.1016/j.virusres.2020.198235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198235</ArticleId><ArticleId IdType="pmc">PMC7680047</ArticleId><ArticleId IdType="pubmed">33232783</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranow C. Vitamin D and the immune system. J. Investig. Med. 2011;59:881&#x2013;886. doi: 10.2310/JIM.0b013e31821b8755.</Citation><ArticleIdList><ArticleId IdType="doi">10.2310/JIM.0b013e31821b8755</ArticleId><ArticleId IdType="pmc">PMC3166406</ArticleId><ArticleId IdType="pubmed">21527855</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, et al. Vitamin D: a role also in long COVID-19? Nutrients. 2022;14:1625. doi: 10.3390/nu14081625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081625</ArticleId><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12040988</ArticleId><ArticleId IdType="pmc">PMC7352449</ArticleId><ArticleId IdType="pubmed">32492787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transpl. 2006;21:889&#x2013;897. doi: 10.1093/ndt/gfi254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfi254</ArticleId><ArticleId IdType="pubmed">16455676</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy S. Gut microbiome, vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection. Inflamm. Res. 2022;71:13&#x2013;26. doi: 10.1007/s00011-021-01510-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01510-w</ArticleId><ArticleId IdType="pmc">PMC8568567</ArticleId><ArticleId IdType="pubmed">34738147</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaran N, et al. The relationship between vitamin D and the severity of COVID-19. Bratisl. Lek. Listy. 2021;122:200&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">33618529</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir EK, Thenappan T, Bhargava M, Chen Y. Does vitamin D deficiency increase the severity of COVID-19? Clin. Med. (Lond.) 2020;20:e107&#x2013;e108. doi: 10.7861/clinmed.2020-0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0301</ArticleId><ArticleId IdType="pmc">PMC7385774</ArticleId><ArticleId IdType="pubmed">32503801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira M, Dantas Damascena A, Galv&#xe3;o Azevedo LM, de Almeida Oliveira T, da Mota Santana J. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2022;62:1308&#x2013;1316. doi: 10.1080/10408398.2020.1841090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2020.1841090</ArticleId><ArticleId IdType="pubmed">33146028</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshkhah A, et al. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin. Exp. Res. 2020;32:2141&#x2013;2158. doi: 10.1007/s40520-020-01677-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01677-y</ArticleId><ArticleId IdType="pmc">PMC7465887</ArticleId><ArticleId IdType="pubmed">32876941</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, et al. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. J. Clin. Endocrinol. Metab. 2023;108:e1106&#x2013;e1116. doi: 10.1210/clinem/dgad207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, et al. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol. (Torino) 2021;46:177&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">33213116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez AM, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J. Steroid Biochem. Mol. Biol. 2010;118:142&#x2013;150. doi: 10.1016/j.jsbmb.2009.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2009.11.004</ArticleId><ArticleId IdType="pmc">PMC2821704</ArticleId><ArticleId IdType="pubmed">19931390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, et al. Vitamin D and its therapeutic relevance in pulmonary diseases. J. Nutr. Biochem. 2021;90:108571. doi: 10.1016/j.jnutbio.2020.108571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2020.108571</ArticleId><ArticleId IdType="pubmed">33388351</ArticleId></ArticleIdList></Reference><Reference><Citation>Salabei JK, et al. COVID-19 and the cardiovascular system: an update. Am. J. Med. Sci. 2022;364:139&#x2013;147. doi: 10.1016/j.amjms.2022.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2022.01.022</ArticleId><ArticleId IdType="pmc">PMC8830924</ArticleId><ArticleId IdType="pubmed">35151635</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya P, et al. The effects of vitamin D supplementation and 25-hydroxyvitamin D levels on the risk of myocardial infarction and mortality. J. Endocr. Soc. 2021;5:bvab124. doi: 10.1210/jendso/bvab124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab124</ArticleId><ArticleId IdType="pmc">PMC8358990</ArticleId><ArticleId IdType="pubmed">34396023</ArticleId></ArticleIdList></Reference><Reference><Citation>Oristrell J, et al. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J. Endocrinol. Invest. 2022;45:167&#x2013;179. doi: 10.1007/s40618-021-01639-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01639-9</ArticleId><ArticleId IdType="pmc">PMC8285728</ArticleId><ArticleId IdType="pubmed">34273098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf8;sj&#xf8; E, et al. Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. Mult. Scler. 2017;23:395&#x2013;402. doi: 10.1177/1352458516654310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458516654310</ArticleId><ArticleId IdType="pubmed">27325604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemb P, et al. Vitamin D deficiency and the COVID-19 pandemic. J. Glob. Antimicrob. Resist. 2020;22:133&#x2013;134. doi: 10.1016/j.jgar.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgar.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7256612</ArticleId><ArticleId IdType="pubmed">32474141</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharm. 2013;75:645&#x2013;662. doi: 10.1111/j.1365-2125.2012.04374.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2012.04374.x</ArticleId><ArticleId IdType="pmc">PMC3575932</ArticleId><ArticleId IdType="pubmed">22765297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathaway D, et al. Omega 3 fatty acids and COVID-19: a comprehensive review. Infect. Chemother. 2020;52:478&#x2013;495. doi: 10.3947/ic.2020.52.4.478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2020.52.4.478</ArticleId><ArticleId IdType="pmc">PMC7779984</ArticleId><ArticleId IdType="pubmed">33377319</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. Int J. Mol. Sci. 2019;20:5028. doi: 10.3390/ijms20205028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205028</ArticleId><ArticleId IdType="pmc">PMC6834330</ArticleId><ArticleId IdType="pubmed">31614433</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonnesu R, et al. Palmitoylethanolamide (PEA) inhibits SARS-CoV-2 entry by interacting with S protein and ACE-2 receptor. Viruses. 2022;14:1080. doi: 10.3390/v14051080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051080</ArticleId><ArticleId IdType="pmc">PMC9146540</ArticleId><ArticleId IdType="pubmed">35632821</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo A, et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J. Med. Virol. 2020;92:2227&#x2013;2231. doi: 10.1002/jmv.26103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26103</ArticleId><ArticleId IdType="pmc">PMC7301002</ArticleId><ArticleId IdType="pubmed">32484958</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S-K, et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clin. Gastroenterol. Hepatol. 2021;19:1387&#x2013;1394.e2. doi: 10.1016/j.cgh.2020.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C-P, Chang C-M, Yang C-C, Pariante CM, Su K-P. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav. Immun. 2022;103:19&#x2013;27. doi: 10.1016/j.bbi.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020;12:1181. doi: 10.3390/nu12041181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041181</ArticleId><ArticleId IdType="pmc">PMC7469053</ArticleId><ArticleId IdType="pubmed">32756516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata B, et al. Omega-3 index and clinical outcomes of severe COVID-19: preliminary results of a cross-sectional study. Int J. Environ. Res. Public Health. 2021;18:7722. doi: 10.3390/ijerph18157722.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18157722</ArticleId><ArticleId IdType="pmc">PMC8345773</ArticleId><ArticleId IdType="pubmed">34360016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Santana M, et al. Inverse association between omega-3 index and severity of COVID-19: a case-control study. Int J. Environ. Res. Public Health. 2022;19:6445. doi: 10.3390/ijerph19116445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116445</ArticleId><ArticleId IdType="pmc">PMC9180292</ArticleId><ArticleId IdType="pubmed">35682030</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdem D, Segmen F, Uysal E, Kilicarslan G. Effect of omega-3 fatty acid use on sepsis and mortality in patients with Cov&#x131;d-19. Niger. J. Clin. Pr. 2023;26:102&#x2013;108. doi: 10.4103/njcp.njcp_415_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/njcp.njcp_415_22</ArticleId><ArticleId IdType="pubmed">36751831</ArticleId></ArticleIdList></Reference><Reference><Citation>Linster CL, Van Schaftingen E. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 2007;274:1&#x2013;22. doi: 10.1111/j.1742-4658.2006.05607.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2006.05607.x</ArticleId><ArticleId IdType="pubmed">17222174</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9:1211. doi: 10.3390/nu9111211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, L. et al. Therapeutic effects of high-dose vitamin C supplementation in patients with covid-19: A meta-analysis. Nutr. Rev.10.1093/nutrit/nuad105 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37682265</ArticleId></ArticleIdList></Reference><Reference><Citation>Olczak-Pruc M, et al. Vitamin C supplementation for the treatment of COVID-19: a systematic review and meta-analysis. Nutrients. 2022;14:4217. doi: 10.3390/nu14194217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14194217</ArticleId><ArticleId IdType="pmc">PMC9570769</ArticleId><ArticleId IdType="pubmed">36235869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafez W, et al. Vitamin C as a potential interplaying factor between obesity and COVID-19 outcome. Healthcare (Basel) 2022;11:93. doi: 10.3390/healthcare11010093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11010093</ArticleId><ArticleId IdType="pmc">PMC9819584</ArticleId><ArticleId IdType="pubmed">36611553</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, et al. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterol. Motil. 2021;33:e14104. doi: 10.1111/nmo.14104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14104</ArticleId><ArticleId IdType="pmc">PMC7995160</ArticleId><ArticleId IdType="pubmed">33591607</ArticleId></ArticleIdList></Reference><Reference><Citation>Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol. Life Sci. 2019;76:473&#x2013;493. doi: 10.1007/s00018-018-2943-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2943-4</ArticleId><ArticleId IdType="pmc">PMC11105460</ArticleId><ArticleId IdType="pubmed">30317530</ArticleId></ArticleIdList></Reference><Reference><Citation>Suez J, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022;185:3307&#x2013;3328.e19. doi: 10.1016/j.cell.2022.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.07.016</ArticleId><ArticleId IdType="pubmed">35987213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdel-Sulkowska EM. Neuropsychiatric ramifications of COVID-19: short-chain fatty acid deficiency and disturbance of microbiota-gut-brain axis signaling. Biomed. Res. Int. 2021;2021:7880448. doi: 10.1155/2021/7880448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7880448</ArticleId><ArticleId IdType="pmc">PMC8510788</ArticleId><ArticleId IdType="pubmed">34651049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N, et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 2021;12:1618. doi: 10.1038/s41467-021-21907-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21907-9</ArticleId><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S, Pays L. Molecular insights into SARS-CoV2-induced alterations of the gut/brain axis. Int J. Mol. Sci. 2021;22:10440. doi: 10.3390/ijms221910440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910440</ArticleId><ArticleId IdType="pmc">PMC8508788</ArticleId><ArticleId IdType="pubmed">34638785</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB) Crit. Rev. Food Sci. Nutr. 1999;39:13&#x2013;126. doi: 10.1080/10408699991279187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408699991279187</ArticleId><ArticleId IdType="pubmed">10028126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasti AN, Synodinou KD, Pyrousis IA, Nikolaki MD, Triantafyllou KD. Probiotics regulating inflammation via NLRP3 inflammasome modulation: a potential therapeutic approach for COVID-19. Microorganisms. 2021;9:2376. doi: 10.3390/microorganisms9112376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9112376</ArticleId><ArticleId IdType="pmc">PMC8624812</ArticleId><ArticleId IdType="pubmed">34835501</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Ettorre G, et al. Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front. Med. (Lausanne) 2020;7:389. doi: 10.3389/fmed.2020.00389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00389</ArticleId><ArticleId IdType="pmc">PMC7358304</ArticleId><ArticleId IdType="pubmed">32733907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, et al. The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy. Clin. Transl. Med. 2021;11:e643. doi: 10.1002/ctm2.643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.643</ArticleId><ArticleId IdType="pmc">PMC8713143</ArticleId><ArticleId IdType="pubmed">34962356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham MT, et al. Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein. J. Nutr. Biochem. 2021;98:108821. doi: 10.1016/j.jnutbio.2021.108821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2021.108821</ArticleId><ArticleId IdType="pmc">PMC8277543</ArticleId><ArticleId IdType="pubmed">34271099</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Castrell&#xf3;n P, et al. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 2022;14:2018899. doi: 10.1080/19490976.2021.2018899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018899</ArticleId><ArticleId IdType="pmc">PMC8757475</ArticleId><ArticleId IdType="pubmed">35014600</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. Boosting vaccine-elicited respiratory mucosal and systemic COVID-19 immunity in mice with the oral Lactobacillus plantarum. Front Nutr. 2021;8:789242. doi: 10.3389/fnut.2021.789242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.789242</ArticleId><ArticleId IdType="pmc">PMC8733898</ArticleId><ArticleId IdType="pubmed">35004816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Ferreiro A, et al. Effects of loigolactobacillus coryniformis K8 CECT 5711 on the immune response of elderly subjects to COVID-19 vaccination: a randomized controlled trial. Nutrients. 2022;14:228. doi: 10.3390/nu14010228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14010228</ArticleId><ArticleId IdType="pmc">PMC8747230</ArticleId><ArticleId IdType="pubmed">35011103</ArticleId></ArticleIdList></Reference><Reference><Citation>Synodinou KD, Nikolaki MD, Triantafyllou K, Kasti AN. Immunomodulatory effects of probiotics on COVID-19 infection by targeting the gut-lung axis microbial cross-talk. Microorganisms. 2022;10:1764. doi: 10.3390/microorganisms10091764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10091764</ArticleId><ArticleId IdType="pmc">PMC9505869</ArticleId><ArticleId IdType="pubmed">36144365</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M, Honce R, Schultz-Cherry S. Metabolic syndrome and viral pathogenesis: lessons from influenza and coronaviruses. J. Virol. 2020;94:e00665&#x2013;20. doi: 10.1128/JVI.00665-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00665-20</ArticleId><ArticleId IdType="pmc">PMC7459568</ArticleId><ArticleId IdType="pubmed">32661141</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur B, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci. Rep. 2021;11:8562. doi: 10.1038/s41598-021-88130-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88130-w</ArticleId><ArticleId IdType="pmc">PMC8058064</ArticleId><ArticleId IdType="pubmed">33879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782&#x2013;792. doi: 10.1016/S2213-8587(20)30238-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 2021;17:135&#x2013;149. doi: 10.1038/s41574-020-00462-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00462-1</ArticleId><ArticleId IdType="pubmed">33479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz PEH, et al. Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC Health Promotion Series. J. Am. Coll. Cardiol. 2018;72:1829&#x2013;1844. doi: 10.1016/j.jacc.2018.07.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.07.081</ArticleId><ArticleId IdType="pmc">PMC6709577</ArticleId><ArticleId IdType="pubmed">30286928</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos A, Magro DO, Evangelista-Poderoso R, Saad MJA. Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. Diabetol. Metab. Syndr. 2021;13:23. doi: 10.1186/s13098-021-00639-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-021-00639-2</ArticleId><ArticleId IdType="pmc">PMC7919999</ArticleId><ArticleId IdType="pubmed">33648564</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9:786&#x2013;798. doi: 10.1016/S2213-8587(21)00244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00244-8</ArticleId><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-T, et al. SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metab. 2021;33:1565&#x2013;1576.e5. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji N, et al. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerg. Microbes Infect. 2022;11:1115&#x2013;1125. doi: 10.1080/22221751.2022.2059400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2059400</ArticleId><ArticleId IdType="pmc">PMC9037197</ArticleId><ArticleId IdType="pubmed">35343389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Liposome-embedded SOD attenuated DSS-induced ulcerative colitis in mice by ameliorating oxidative stress and intestinal barrier dysfunction. Food Funct. 2023;14:4392&#x2013;4405. doi: 10.1039/D2FO03312G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO03312G</ArticleId><ArticleId IdType="pubmed">37092895</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, et al. Glucose-lowering effects of orally administered superoxide dismutase in type 2 diabetic model rats. NPJ Sci. Food. 2022;6:36. doi: 10.1038/s41538-022-00151-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41538-022-00151-5</ArticleId><ArticleId IdType="pmc">PMC9392803</ArticleId><ArticleId IdType="pubmed">35987753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutmair S, et al. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021;54:1578&#x2013;1593.e5. doi: 10.1016/j.immuni.2021.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.002</ArticleId><ArticleId IdType="pmc">PMC8106882</ArticleId><ArticleId IdType="pubmed">34051147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupte M, et al. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;295:R781&#x2013;R788. doi: 10.1152/ajpregu.00183.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00183.2008</ArticleId><ArticleId IdType="pmc">PMC2536864</ArticleId><ArticleId IdType="pubmed">18650320</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021;33:2174&#x2013;2188.e5. doi: 10.1016/j.cmet.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab. Res. Rev. 2020;36:e3319. doi: 10.1002/dmrr.3319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3319</ArticleId><ArticleId IdType="pmc">PMC7228407</ArticleId><ArticleId IdType="pubmed">32233013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zickler M, et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 2022;34:1&#x2013;2. doi: 10.1016/j.cmet.2021.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8663969</ArticleId><ArticleId IdType="pubmed">34895500</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharm. Ther. 2021;225:107843. doi: 10.1016/j.pharmthera.2021.107843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107843</ArticleId><ArticleId IdType="pmc">PMC8011334</ArticleId><ArticleId IdType="pubmed">33811957</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K-C, et al. A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study. Biomed. Pharmacother. 2021;133:111037. doi: 10.1016/j.biopha.2020.111037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111037</ArticleId><ArticleId IdType="pmc">PMC7676327</ArticleId><ArticleId IdType="pubmed">33249281</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, et al. Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: a prospective cohort and nested case-control study. Chin. J. Integr. Med. 2021;27:245&#x2013;251. doi: 10.1007/s11655-021-3328-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-021-3328-3</ArticleId><ArticleId IdType="pmc">PMC7857094</ArticleId><ArticleId IdType="pubmed">33534076</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, et al. The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine. Front. Pharm. 2022;13:1054312. doi: 10.3389/fphar.2022.1054312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1054312</ArticleId><ArticleId IdType="pmc">PMC9872123</ArticleId><ArticleId IdType="pubmed">36703736</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Treatment of COVID-19 anxiety by auricular points: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28984. doi: 10.1097/MD.0000000000028984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000028984</ArticleId><ArticleId IdType="pmc">PMC8913093</ArticleId><ArticleId IdType="pubmed">35451390</ArticleId></ArticleIdList></Reference><Reference><Citation>Volf N, Salques V, Lassaux A. An auricular marker for COVID-19. Med. Acupunct. 2020;32:174&#x2013;175. doi: 10.1089/acu.2020.29151.vlf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acu.2020.29151.vlf</ArticleId><ArticleId IdType="pmc">PMC7464934</ArticleId><ArticleId IdType="pubmed">32913482</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, et al. The beneficial role of auricular point pressure in insomnia and anxiety in isolated COVID-19 patients. Evid. Based Complement Altern. Med. 2021;2021:6611942. doi: 10.1155/2021/6611942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6611942</ArticleId><ArticleId IdType="pmc">PMC8282373</ArticleId><ArticleId IdType="pubmed">34306148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W-X, Fan AY, Chen S, Alemi SF. Acupuncture modulates immunity in sepsis: toward a science-based protocol. Auton. Neurosci. 2021;232:102793. doi: 10.1016/j.autneu.2021.102793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102793</ArticleId><ArticleId IdType="pubmed">33684727</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, B.-W. &amp; Rong, P.-J. Acupoint stimulation for long COVID: A promising intervention. World J. Acupunct. Moxibustion33, 191&#x2013;197 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232723</ArticleId><ArticleId IdType="pubmed">37363407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho P, et al. Perspective adjunctive therapies for COVID-19: beyond antiviral therapy. Int J. Med. Sci. 2021;18:314&#x2013;324. doi: 10.7150/ijms.51935.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.51935</ArticleId><ArticleId IdType="pmc">PMC7757136</ArticleId><ArticleId IdType="pubmed">33390800</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu SAG, Mustafa G, Clemens RA, Naidu AS. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-dependent RNA polymerase complex (nsp7/nsp8/nsp12) of SARS-CoV-2. J. Diet. Suppl. 2023;20:254&#x2013;283. doi: 10.1080/19390211.2021.2006387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2021.2006387</ArticleId><ArticleId IdType="pubmed">34850656</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu SAG, Tripathi YB, Shree P, Clemens RA, Naidu AS. Phytonutrient inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) autocleavage enzyme critical for COVID-19 pathogenesis. J. Diet. Suppl. 2023;20:284&#x2013;311. doi: 10.1080/19390211.2021.2006388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2021.2006388</ArticleId><ArticleId IdType="pubmed">34821532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachar SC, Mazumder K, Bachar R, Aktar A, Al Mahtab M. A review of medicinal plants with antiviral activity available in bangladesh and mechanistic insight into their bioactive metabolites on SARS-CoV-2, HIV and HBV. Front. Pharm. 2021;12:732891. doi: 10.3389/fphar.2021.732891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.732891</ArticleId><ArticleId IdType="pmc">PMC8606584</ArticleId><ArticleId IdType="pubmed">34819855</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawrot J, et al. Medicinal herbs in the relief of neurological, cardiovascular, and respiratory symptoms after COVID-19 infection a literature review. Cells. 2022;11:1897. doi: 10.3390/cells11121897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11121897</ArticleId><ArticleId IdType="pmc">PMC9220793</ArticleId><ArticleId IdType="pubmed">35741026</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi HA, et al. Medicinal plants and isolated molecules demonstrating immunomodulation activity as potential alternative therapies for viral diseases including COVID-19. Front. Immunol. 2021;12:637553. doi: 10.3389/fimmu.2021.637553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.637553</ArticleId><ArticleId IdType="pmc">PMC8155592</ArticleId><ArticleId IdType="pubmed">34054806</ArticleId></ArticleIdList></Reference><Reference><Citation>Borse S, et al. Ayurveda botanicals in COVID-19 management: an in silico multi-target approach. PLoS ONE. 2021;16:e0248479. doi: 10.1371/journal.pone.0248479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248479</ArticleId><ArticleId IdType="pmc">PMC8195371</ArticleId><ArticleId IdType="pubmed">34115763</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K, et al. Inhibition of SARS-CoV2 viral infection with natural antiviral plants constituents: an in-silico approach. J. King Saud. Univ. Sci. 2023;35:102534. doi: 10.1016/j.jksus.2022.102534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jksus.2022.102534</ArticleId><ArticleId IdType="pmc">PMC9811905</ArticleId><ArticleId IdType="pubmed">36619666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta I, Baranwal P, Singh G, Gupta V. Mucormycosis, past and present: a comprehensive review. Future Microbiol. 2023;18:217&#x2013;234. doi: 10.2217/fmb-2022-0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0141</ArticleId><ArticleId IdType="pubmed">36970978</ArticleId></ArticleIdList></Reference><Reference><Citation>Madikonda PK, Perugu SB, Ramadevi CH. Effect of Ayurvedic Intervention as an adjunct therapy in Post COVID-19 Mucormycosis (PCM): a non-randomized parallel group study. J. Ayurveda Integr. Med. 2022;13:100672. doi: 10.1016/j.jaim.2022.100672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2022.100672</ArticleId><ArticleId IdType="pmc">PMC9606040</ArticleId><ArticleId IdType="pubmed">36317082</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rard M, et al. Long-term evolution of malnutrition and loss of muscle strength after COVID-19: a major and neglected component of long COVID-19. Nutrients. 2021;13:3964. doi: 10.3390/nu13113964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113964</ArticleId><ArticleId IdType="pmc">PMC8618979</ArticleId><ArticleId IdType="pubmed">34836219</ArticleId></ArticleIdList></Reference><Reference><Citation>Capela Santos D, et al. Yoga for COVID-19: An ancient practice for a new condition&#x2014;a literature review. Complement Ther. Clin. Pr. 2023;50:101717. doi: 10.1016/j.ctcp.2022.101717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctcp.2022.101717</ArticleId><ArticleId IdType="pmc">PMC9744485</ArticleId><ArticleId IdType="pubmed">36525872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7:e001735. doi: 10.1136/rmdopen-2021-001735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiani AK, et al. Neurobiological basis of chiropractic manipulative treatment of the spine in the care of major depression. Acta Biomed. 2020;91:e2020006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023121</ArticleId><ArticleId IdType="pubmed">33170171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu EC-P, Lee LY-K. Cervical spondylosis as a hidden contributing factor to fibromyalgia: a case report. Int. Med. Case Rep. J. 2022;15:639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9653028</ArticleId><ArticleId IdType="pubmed">36388239</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen S, et al. Peripheral electrical stimulation paired with movement-related cortical potentials improves isometric muscle strength and voluntary activation following stroke. Front. Hum. Neurosci. 2020;14:156. doi: 10.3389/fnhum.2020.00156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2020.00156</ArticleId><ArticleId IdType="pmc">PMC7242792</ArticleId><ArticleId IdType="pubmed">32499686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaibi A, Benth J&#x160;, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur. J. Neurol. 2017;24:143&#x2013;153. doi: 10.1111/ene.13166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13166</ArticleId><ArticleId IdType="pmc">PMC5214068</ArticleId><ArticleId IdType="pubmed">27696633</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus K, Asgharifar S, Gleberzon B. What effect does chiropractic treatment have on gastrointestinal (GI) disorders: a narrative review of the literature. J. Can. Chiropr. Assoc. 2015;59:122&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486990</ArticleId><ArticleId IdType="pubmed">26136604</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris HMB, Hill C. A place for viruses on the tree of life. Front. Microbiol. 2020;11:604048. doi: 10.3389/fmicb.2020.604048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.604048</ArticleId><ArticleId IdType="pmc">PMC7840587</ArticleId><ArticleId IdType="pubmed">33519747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Yoshinaga SK, Shibue K, Mak TW. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 2021;28:3199&#x2013;3213. doi: 10.1038/s41418-021-00892-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00892-y</ArticleId><ArticleId IdType="pmc">PMC8522258</ArticleId><ArticleId IdType="pubmed">34663907</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D. Sphingolipids as modulators of SARS-CoV-2 infection. Front Cell Dev. Biol. 2021;9:689854. doi: 10.3389/fcell.2021.689854.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.689854</ArticleId><ArticleId IdType="pmc">PMC8245774</ArticleId><ArticleId IdType="pubmed">34222257</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoodi M, et al. Disturbed lipid and amino acid metabolisms in COVID-19 patients. J. Mol. Med (Berl.) 2022;100:555&#x2013;568. doi: 10.1007/s00109-022-02177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-022-02177-4</ArticleId><ArticleId IdType="pmc">PMC8783191</ArticleId><ArticleId IdType="pubmed">35064792</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlass U, et al. Marked elevation of lipase in COVID-19 disease: a cohort study. Clin. Transl. Gastroenterol. 2020;11:e00215. doi: 10.14309/ctg.0000000000000215.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000215</ArticleId><ArticleId IdType="pmc">PMC7386395</ArticleId><ArticleId IdType="pubmed">32764201</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 2012;13:465&#x2013;477. doi: 10.1038/nrn3257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3257</ArticleId><ArticleId IdType="pmc">PMC3681811</ArticleId><ArticleId IdType="pubmed">22678511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostner JM, et al. Tryptophan metabolism and related pathways in psychoneuroimmunology: the impact of nutrition and lifestyle. Neuropsychobiology. 2020;79:89&#x2013;99. doi: 10.1159/000496293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000496293</ArticleId><ArticleId IdType="pubmed">30808841</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, et al. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci. Rep. 2020;10:16824. doi: 10.1038/s41598-020-73966-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73966-5</ArticleId><ArticleId IdType="pmc">PMC7544910</ArticleId><ArticleId IdType="pubmed">33033346</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>